1,735 results on '"Gleave, Martin E."'
Search Results
2. DPYSL5 is highly expressed in treatment-induced neuroendocrine prostate cancer and promotes lineage plasticity via EZH2/PRC2
- Author
-
Kaarijärvi, Roosa, Kaljunen, Heidi, Nappi, Lucia, Fazli, Ladan, Kung, Sonia H. Y., Hartikainen, Jaana M., Paakinaho, Ville, Capra, Janne, Rilla, Kirsi, Malinen, Marjo, Mäkinen, Petri I., Ylä-Herttuala, Seppo, Zoubeidi, Amina, Wang, Yuzhuo, Gleave, Martin E., Hiltunen, Mikko, and Ketola, Kirsi
- Published
- 2024
- Full Text
- View/download PDF
3. High expression of Trop2 is associated with aggressive localized prostate cancer and is a candidate urinary biomarker
- Author
-
Liu, Shiqin, Hawley, Sarah J., Kunder, Christian A., Hsu, En-Chi, Shen, Michelle, Westphalen, Lennart, Auman, Heidi, Newcomb, Lisa F., Lin, Daniel W., Nelson, Peter S., Feng, Ziding, Tretiakova, Maria S., True, Lawrence D., Vakar-Lopez, Funda, Carroll, Peter R., Simko, Jeffry, Gleave, Martin E., Troyer, Dean A., McKenney, Jesse K., Brooks, James D., Liss, Michael A., and Stoyanova, Tanya
- Published
- 2024
- Full Text
- View/download PDF
4. Germline mutations in penetrant cancer predisposition genes are rare in men with prostate cancer selecting active surveillance
- Author
-
Brady, Lauren, Newcomb, Lisa F, Zhu, Kehao, Zheng, Yingye, Boyer, Hilary, De Sarkar, Navonil, McKenney, Jesse K, Brooks, James D, Carroll, Peter R, Dash, Atreya, Ellis, William J, Filson, Christopher P, Gleave, Martin E, Liss, Michael A, Martin, Frances, Morgan, Todd M, Thompson, Ian M, Wagner, Andrew A, Pritchard, Colin C, Lin, Daniel W, and Nelson, Peter S
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Oncology and Carcinogenesis ,Prevention ,Cancer ,Prostate Cancer ,Genetics ,Urologic Diseases ,Aetiology ,2.1 Biological and endogenous factors ,Good Health and Well Being ,Male ,Humans ,Germ-Line Mutation ,Watchful Waiting ,Retrospective Studies ,Prostatic Neoplasms ,Genes ,BRCA2 ,Genetic Predisposition to Disease ,active surveillance ,adverse pathology ,germline mutations ,prostate cancer ,Biochemistry and Cell Biology ,Oncology and carcinogenesis - Abstract
BackgroundPathogenic germline mutations in several rare penetrant cancer predisposition genes are associated with an increased risk of aggressive prostate cancer (PC). Our objectives were to determine the prevalence of pathogenic germline mutations in men with low-risk PC on active surveillance, and assess whether pathogenic germline mutations associate with grade reclassification or adverse pathology, recurrence, or metastases, in men treated after initial surveillance.MethodsMen prospectively enrolled in the Canary Prostate Active Surveillance Study (PASS) were retrospectively sampled for the study. Germline DNA was sequenced utilizing a hereditary cancer gene panel. Mutations were classified according to the American College of Clinical Genetics and Genomics' guidelines. The association of pathogenic germline mutations with grade reclassification and adverse characteristics was evaluated by weighted Cox proportional hazards modeling and conditional logistic regression, respectively.ResultsOverall, 29 of 437 (6.6%) study participants harbored a pathogenic germline mutation of which 19 occurred in a gene involved in DNA repair (4.3%). Eight participants (1.8%) had pathogenic germline mutations in three genes associated with aggressive PC: ATM, BRCA1, and BRCA2. The presence of pathogenic germline mutations in DNA repair genes did not associate with adverse characteristics (univariate analysis HR = 0.87, 95% CI: 0.36-2.06, p = 0.7). The carrier rates of pathogenic germline mutations in ATM, BRCA1, and BRCA2did not differ in men with or without grade reclassification (1.9% vs. 1.8%).ConclusionThe frequency of pathogenic germline mutations in penetrant cancer predisposition genes is extremely low in men with PC undergoing active surveillance and pathogenic germline mutations had no apparent association with grade reclassification or adverse characteristics.
- Published
- 2022
5. Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC)
- Author
-
Gillessen, Silke, Turco, Fabio, Davis, Ian D., Efstathiou, Jason A., Fizazi, Karim, James, Nicholas D., Shore, Neal, Small, Eric, Smith, Matthew, Sweeney, Christopher J., Tombal, Bertrand, Zilli, Thomas, Agarwal, Neeraj, Antonarakis, Emmanuel S., Aparicio, Ana, Armstrong, Andrew J., Bastos, Diogo Assed, Attard, Gerhardt, Axcrona, Karol, Ayadi, Mouna, Beltran, Himisha, Bjartell, Anders, Blanchard, Pierre, Bourlon, Maria T., Briganti, Alberto, Bulbul, Muhammad, Buttigliero, Consuelo, Caffo, Orazio, Castellano, Daniel, Castro, Elena, Cheng, Heather H., Chi, Kim N., Clarke, Caroline S., Clarke, Noel, de Bono, Johann S., De Santis, Maria, Duran, Ignacio, Efstathiou, Eleni, Ekeke, Onyeanunam N., El Nahas, Tamer I.H., Emmett, Louise, Fanti, Stefano, Fatiregun, Omolara A., Feng, Felix Y., Fong, Peter C.C., Fonteyne, Valerie, Fossati, Nicola, George, Daniel J., Gleave, Martin E., Gravis, Gwenaelle, Halabi, Susan, Heinrich, Daniel, Herrmann, Ken, Hofman, Michael S., Hope, Thomas A., Horvath, Lisa G., Hussain, Maha H.A., Jereczek-Fossa, Barbara Alicja, Jones, Robert J., Joshua, Anthony M., Kanesvaran, Ravindren, Keizman, Daniel, Khauli, Raja B., Kramer, Gero, Loeb, Stacy, Mahal, Brandon A., Maluf, Fernando C., Mateo, Joaquin, Matheson, David, Matikainen, Mika P., McDermott, Ray, McKay, Rana R., Mehra, Niven, Merseburger, Axel S., Morgans, Alicia K., Morris, Michael J., Mrabti, Hind, Mukherji, Deborah, Murphy, Declan G., Murthy, Vedang, Mutambirwa, Shingai B.A., Nguyen, Paul L., Oh, William K., Ost, Piet, O’Sullivan, Joe M., Padhani, Anwar R., Parker, Chris, Poon, Darren M.C., Pritchard, Colin C., Rabah, Danny M, Rathkopf, Dana, Reiter, Robert E., Renard-Penna, Raphaele, Ryan, Charles J., Saad, Fred, Sade, Juan Pablo, Sandhu, Shahneen, Sartor, Oliver A., Schaeffer, Edward, Scher, Howard I., Sharifi, Nima, Skoneczna, Iwona A., Soule, Howard R., Spratt, Daniel E., Srinivas, Sandy, Sternberg, Cora N., Suzuki, Hiroyoshi, Taplin, Mary-Ellen, Thellenberg-Karlsson, Camilla, Tilki, Derya, Türkeri, Levent N., Uemura, Hiroji, Ürün, Yüksel, Vale, Claire L., Vapiwala, Neha, Walz, Jochen, Yamoah, Kosj, Ye, Dingwei, Yu, Evan Y., Zapatero, Almudena, and Omlin, Aurelius
- Published
- 2025
- Full Text
- View/download PDF
6. Analysis of separate training and validation radical prostatectomy cohorts identifies 0.25 mm diameter as an optimal definition for "large" cribriform prostatic adenocarcinoma.
- Author
-
Chan, Emily, McKenney, Jesse K, Hawley, Sarah, Corrigan, Dillon, Auman, Heidi, Newcomb, Lisa F, Boyer, Hilary D, Carroll, Peter R, Cooperberg, Matthew R, Klein, Eric, Fazli, Ladan, Gleave, Martin E, Hurtado-Coll, Antonio, Simko, Jeffry P, Nelson, Peter S, Thompson, Ian M, Tretiakova, Maria S, Troyer, Dean, True, Lawrence D, Vakar-Lopez, Funda, Lin, Daniel W, Brooks, James D, Feng, Ziding, and Nguyen, Jane K
- Subjects
Humans ,Adenocarcinoma ,Prostatic Neoplasms ,Prostatectomy ,Retrospective Studies ,Male ,Neoplasm Grading ,Clinical Research ,Cancer ,Medical and Health Sciences ,Pathology - Abstract
Cribriform growth pattern is well-established as an adverse pathologic feature in prostate cancer. The literature suggests "large" cribriform glands associate with aggressive behavior; however, published studies use varying definitions for "large". We aimed to identify an outcome-based quantitative cut-off for "large" vs "small" cribriform glands. We conducted an initial training phase using the tissue microarray based Canary retrospective radical prostatectomy cohort. Of 1287 patients analyzed, cribriform growth was observed in 307 (24%). Using Kaplan-Meier estimates of recurrence-free survival curves (RFS) that were stratified by cribriform gland size, we identified 0.25 mm as the optimal cutoff to identify more aggressive disease. In univariable and multivariable Cox proportional hazard analyses, size >0.25 mm was a significant predictor of worse RFS compared to patients with cribriform glands ≤0.25 mm, independent of pre-operative PSA, grade, stage and margin status (p 0.25 mm had a significantly lower RFS relative to patients with cribriform glands ≤0.25 mm (each subset p = 0.004). Furthermore, there was no significant difference in outcomes between patients with cribriform glands ≤ 0.25 mm and patients without cribriform glands. The >0.25 mm cut-off was validated as statistically significant in a separate 419 patient, completely embedded whole-section radical prostatectomy cohort by biochemical recurrence, metastasis-free survival, and disease specific death, even when cases with admixed Gleason pattern 5 carcinoma were excluded. In summary, our findings support reporting cribriform gland size and identify 0.25 mm as an optimal outcome-based quantitative measure for defining "large" cribriform glands. Moreover, cribriform glands >0.25 mm are associated with potential for metastatic disease independent of Gleason pattern 5 adenocarcinoma.
- Published
- 2022
7. Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial
- Author
-
Amos, Claire, Beaney, Katherine, Bellenger, Katharine, Brawley, Chris, Chung, Christina, Cook, Adrian, Embleton, Andrew, Forcat, Silvia, Goldstein, Cindy, Grabey, Jenna, Hague, Dominic, Herasimtschuk, Anna, Islam, Zaheer, Jovic, Gordana, Maniatis, Christos, Masters, Lindsey, Mohamed, Fatima, Morgan, Rachel, Murphy, Claire, Noor, Dipa, Parmar, Max, Patterson, Paul, Pickering, Holly, Pugh, Cheryl, Rauchenberger, Mary, Ribeiro, Helena, Roach, Carol, Seray-Wurie, Fatimah, Shaji, Preetha, Sims, Hannah, Spittle, Ben, Sydes, Matthew, Tappenden, Nancy, Tsang, Lilian, Uscinska, Barbara, Brown, Teddy, Casey, Sue, Davidson, Cathy, Dellar, Conor, Fletcher, Mandy, Meyer, Ralph, Murphy, Karen, Parulekar, Wendy, Richardson, Harriet, Richardson, Karen, Whelan, Kate, Bissett, Donald, Bonner-Shand, Shelagh, Grant, Judith, Lynch, Rory, MacDonald, Graham, McWilliam, Marie, Moir, Rachel, Rodwell, Sue, Shearer, Kirsty, Smith, Margaret, Binns, Louise, Briggs, Maxine, Brown, Simon, Casanova, Nathalie, Clark, Katy, Hartley, Jasmine, Henry, Ann, Henson, Helen, Hill, Pipa, Jeyasanger, Ganesan, McAlister, Judy, Parkinson, Sharron, Shaw, Alison, Alcock, Christopher, Brady, Joanne, Camilleri, Philip, Carpenter, Janice, Hogbin, Emma, Hyde, Katherine, Kavanagh, Roisin, Ngumo, Alice, Padilla-Harris, Cheryl, Panakis, Niki, Pwint, Thinn, Sabharwal, Ami, Stammers, Tracey, Stone, Helena, Varley, Gail, Weaver, Andrew, Wynn, Hazel, Allan, Elaine, Ansari, Jawaher, Cannon, Philip, Carruthers, Ross, Coubrough, Claudia, Cowan, Chloe, Glen, Hilary, Graham, Janet, Hardie, Maryon, Love, Clare, Macleod, Nicholas, Mahmood, Rana, McClements, Jane, McGlynn, Brian, McKernan, Margaret, Mcleod, Nick, Othman, Aqilah, Ross, Kristy, Roxburgh, Patricia, Templeton, Maureen, Tufail, Aisha, Turley, Claudia, Wilson, Mark, Ali, Zulfiqer, Andrews, Kelly, Burns, Rebecca, Butterworth, Caryl, Coventry, Thomas, Evans, Angela, Jones, Gareth, Lewis, Sion, Oommen, Nikhil, Owen, Susan, Saxton, Wendy, Tapping, Sister Hayley, Thomas, Dianne, Thomas, Rachel, Walker, Beth, Williams, Rachel, Collard, Susan, Ford, Victoria, Goodhind, Frances, Holbrook, Becky, Kershaw, Elizabeth, Ley, Samantha, Martinez, Maria, McCormack, Anne, Sheehan, Denise, Toy, Elizabeth, Van-Koutrik, Lynne, Varughese, Mohini, Aitken, Katherine, Barlow, David, Beattie, Louise, Bownie-Mukumbu, Godfrey, Bryan, Rachel, Corner, Victoria, Edwards, Abigail, Fazekasne Fulep, Adrienn, Guerrero-Urbano, Teresa, Gwilt, Julie, Happle, Liz, Jackman, Dee, Krysta, Beata, Paisey, Sangeeta, Shaffer, Richard, Smith, Jackie, Westley, Rosalyne, Yusof, Hilawati, Appleby, Rowan, Avis, Joanne, Beresford, Mark, Brydon-Hill, Ruth, Cox, Christine, Curtis, Samantha, Elwell, Christine, Frim, Olivera, Hamilton, Beatrice, Hudson, Zoe, Jenner, Abigail, Mantle, Mark, Mason, Jessica, Masson, Susan, McFarlane, Jonathan, Newman, Hugh, Pocock, Abigail, Robertson, Bryony, Tomlinson, Eve, Wassall, Rebecca, Williams (Née Allen), Sister Tania, Brown, Grace, Clarke, Peter, Cole, Aiden, Cousins, Jane, Gilchrist, Gail, Hagan, Chris, Hanna, Emma, Harney, Jackie, Hetherington, Stacey, Houghton, Fionnuala, Hynds, Sharon, Jain, Suneil, Johnston, Ruth, Keane, Patrick, Lyons, Ciara, McAleese, Jonathan, McAllister, Jo, McKenna, Karen, Mitchell, Darren, Murray, Stacey, O'Sullivan, Joe, Rajan, Nambi, Shum, Poh Lin, Stewart, David, Stranex, Stephen, Totten, Grace, Chandrashekara, Madhura, Drew, Ellen, Drew, Mary (Ellen), Fletcher, Julie, Gamble, Tina, Lokes, Rachel, Schumacher, Ann, Shetty, Kavitha, Sohanpal, Sundip, Whitehouse, James, Zarkar, Anjali, Ford, Daniel, Glaholm, John, Lenton, Daniel, O'Beney, Rachael, Taylor, Helen, Thomas, Helen, Chetiyawardana, Samantha, Doherty, A, El-Modir, Ahmed, Gunn, Melanie, James, Nicholas, Kedge, Liz, Mannan, Aliyah, Marange, Josephine, Morrison, Andrew, Okubanjo, Maryanne, Olaniyi-Oduntan, Darlletta, Peterkin, Zhane, Preece, George, Qureshi, Zayn, Ross, Liliam, Samra, Tarandip, Southgate, Elizabeth, Stephens, Rebekah, Stevenson, Robert, Watson-Jones, Phillip, Abdulwahid, Danya, Ainsworth, Sarah, Ashworth, Sue, Beard, Karen, Charnley, Natalie, Desai, Parth, Fielding, Bethany, Flaherty, Jan, Forrest, Diane, Frankland, Helen, Haidar, Imran, Hargreaves, Jeanette, Henry, Joanne, Hugill, Angela, Jewers, Karen, Keith, Sarah, Kilroy, Stephen, King, Jennifer, Parikh, Omi, Riley, Karen, Ryan-Smith, Janet, Thomas, Jacqueline, Thompson, Catherine, Tickle, Vivienne, Waring, Lynsey, Wise, Marcus, Dawson, Louise, Ditchfield, Julie, Al-Samarraie, Amir, Bolger, Annette, Davies, Llinos, Flavin, Aileen, Heron, Jane, Hughes, Faye, Jackson, Kim, Lewis, Joanne, Manley, Rachel, Rutter, Charley-Anne, Smith, Nick, Srinivasan, Vaiku, Stockport, Jane, Thomas, Heather, Toussi, H, Wood, Cathryn, Archer, Simon, Fletcher, Joanne, Ginnelly, Helen, Kirkby, Amy, Knight (n. Sherburn), Victoria, Lawrence nee Palmer, Tara, Mashegede, Beverley, Metcalf, Karen, Panades, Miguel, Sreenivasan, Thiagarajan, Szymiczek, Kinga, Thomas, Isobel, Young, Anita, Broadley, Eve, Brock, Sue, Davies, Joseph, Jones, Stephanie, McCully, Ruby, Naraine, Nicky, Preece, Kate, Purandare, Laura, Rabbi, Taslima, Savage, Sarah, Vamplew, Luke, Bamford, Linda, Benton, Richard, Cotterill, Lauren, Inman, Hayley, Karsera, Louise, Kay, Anne Marie, Kenyon, Lucille, Lazarte, Jannika, McNulty, Dawn, Moore, Eleanor, Nallathambi, Chandran, Naylor, Deirdre, Owen, Lisa, Parikh, Shefali, Pendrill, Amy, Price, Joanne, Robertshaw, Helen, Rodda, Sree, Sewell, Jane, Teo, Mark, Waldron, Eleanor, Bloomfield, David, Blythe, Tracy, Brown, Joanne, Carr, Philippa, Chambers, Carla, Dlodlo, Jessica, Frattaroli, Paul, Gilbert, Duncan, Hart, Andrew, Hodges, Samantha, Hooper, Simon, Hunter, Catherine, Lactao, Ranee, Leitao, Madalena, McKinna, Fiona, Nikapota, Ashok, Peterson, Jane, Robinson, Angus, Tremlett, Jean, Webb, Andrew, Wilkins, Marie, Young, Bobbie, Bahl, Amit, Baxter, Matt, Bowers, Dawn, Challipalli, Amarnath, Coe, Marc, Cowley, Sue, Gillatt, David, Griffiths, Dorothy, Henson (nee Savidge), Verity, Hilman, Serena, Hollister, Robert, Kisanga, Mary, Lee, Vivienne, Lowe, Amelia, Macefield, Rhiannon, Pegler, Ruth, Robertson, Peter, Saldanha, Helen, Simmonds, Mary, Sims, Laura, Wheeler, Lucie, Wilson, Paula, Woods, Martin, Yarrow, Sue, Zelley, Sarah, Abd Alazeez, Mohamed, Alderton, Kate, Brain, Carol, Chilcott, Helen, Clarke, Samantha, Cobos-Arrivabene, Marta, Corderoy, Helen, Cousins, Rebecca, Garner, Victoria, Herbert, Chris, Johnson, Lyndsey, Jones, Kathryn, Kemp, Gail, Kirkby, Sarah, Kirkpatrick, Suriya, Koupparis, Anthony, Manning, Courtney, Oxley, Jon, Perry, Emily, Persad, Raj, Phipps, Charlotte, Richmond-Russell, Kerry, Rowe, Edward, Shelton, Luke, Shiridzinomwa, Constance, Smith, Carolyn, Treasure, Ann, Wyatt, Clare, Beesley, Katherine, Benson, Richard, Couch, Ellie, Foxwell, Sue, Goss, Vanessa, Harnwell, Juliette, Hughes-Davies, Luke, Joslin, Vicky, Laubscher, Angelique, Mazhar, Danish, Patterson, Helen, Raj, Sanjay, Ramanujachar, Ramya, Rimmer, Yvonne, Robinson, Nicola, Russell, Simon, Stone, Matthew, Thomas, Robert, Treeby, Jo, Vickery, Kathryn, Woodward, Cathryn, Ahmed, Ilyas, Appleby, Bonny, Brulinski, Patryk, Buckley, Julie, Catt, Natalie, Coppins, Helen, Crawford, Sister Denise, Davies, Julie-Ann, Drakeley, Susan, Edwards, Albert, Evans, Clary, Galante, Joao, Gladwell, Louise, Gough, Jessica, Hargreaves, Carolyn, Hegarty, Gemma, Kehoe, Laura, Larkins, Rachel, Lipsham, Margaret, Little, Jessica, Malde, Rohit, Middleton, Sharon, Mikropoulos, Christos, Mirza, Arafat, Mithal, Natasha, Nathan, Kannon, Raman, Rakesh, Rendall, Alice, Robinson, Karen, Ryan, Rachel, Sim, Van, Swann, Michelle, Tasker, Lorraine, Taylor, Katy, Thomas, Carys, Trigonis, Ioannis, Walker, Karen, Williams, Joanne, Williamson, Elizabeth, Wood, Marian, Wood, Pauline, Zurakovsky, Hilary, Bois (nee Harris), Elizabeth, Chan, Hin Fan, Chikopela, Loveness, Clark, Helen, Clements, Colette, Holliday, Samantha, Hughes, Owen, Jones, Clare, Kynaston, Howard, Mason, Malcolm, Narahari, Krishna, Pearse, Kevin, Staffurth, John, Austin, Mandy, Barnett, Christian, Camburn, Sister Tracey, Dawson, Elizabeth, Gibson, Sian, Hamid, Abdel, Kancherla, Kiran, Leone, Priscilla, Perkins, Lauren, Ramsay, Valerie, Singizi, Bryan, Allen, Julie, Anderson, Susan, Andrews (nee Moore), Eleanor, Bakawala, Rehana, Beazer, Sarah, Binks, Colin, Bowen, Jo, Broomfield, Barbara, Cook, Audrey, Crossley, Lin, Ford, Chris, Forkes, Janet, Hall, Julia, Healey-Mariano, Jennifer, Jenkins, Peter, Johnson, Nigel, Jonnada, Sai, Owen, Roger, Pratten, Elaine, Sayers, Rachel, Shimell, Chris, Skelton, Amy, Tan, Matthew, Trigg-Hogarth, Kate, Wronski, Sue, Aldous, Mary, Archer, Denise, Eccleson, Helen, Gallimore, Elizabeth, Green, Sue, Ibrahim, Azman, Jones, Carys, Prince, Jude, Chrystal, Melanie, Din, Omar, Firth, Alexandra, Ford, Nicky, Kirkbride, Peter, Martindale, John, Redfearn, Alison, Smedley (nee McCabe), Janine, Smith, Lucy, Sorice, Vittoria, Stevenson, Lesley, Toms, Julie, Wood, Sister Kim, Barke, Nyssa, Basu, Devy, Dewar, Lorna, Driscoll, Celine, Hunting, Liz, Kumar, Muthar, Mabelin, Louies, Muthu Kumar, Dakshinamoorthy, Sizer, Bruce, Thorogood, Lucy, Askew, Sarah, Beech, Darren, Broom, Jane, Duley, Emma, Firth, Elizabeth, Gould, Aaron, Hocking, Christopher, Johns, Louise, Kent, Emma, Madine, John, Partridge, Kerena, Penhaligon, Corrine, Pentecost, Catherine, Pollard, Kay, Poultney, Melissa, Pynsent, William, Skewes, Johanna, Steele, Anita, Thomson, Alastair H, Topps, Alice, Townley, Luke, Wheatley, Duncan, Brown, Maggie, Chan, Andrew, Connor, Marie, Elwell, Sue, Geraghty, Kerry, Griffiths, Theresa, Hayward, Lesley, Humber, Caroline, Khan, Yakhub, Lake, Sister Judith, Laverick, Rosaleen, Mansell, Gemma, Mislang, Albert, Ngwenya, Su, Panesar, Pritpal, Sanders, Kay, Simmons, Elaine, Sinfield, Melanie, Stanley, Laura, Steventon, Emily, Stockdale, Andrew, Sunny, Manju, Thind, Manreet, Tranter, Fiona, Tsalic, Medy, Worlding, Jane, Adamson, Vanessa, Bennion, Carole, Butler-Barnes, Jenny, Hough, Adele, Hough, Chris, Hughes, Joanne, Irwin, P, Javle, P, Logue, John, Mansfield, Carolyn, Smith, Rachel, Sumner, Lesley, Tomlinson, Annabel, Tran, Anna, Walker, Caroline, Wylie, James, Chakraborti, Prabir, Das, Prantik, Ennis, Dawn, Marriott, Sue, Pattu, Pugazhenthi, Ward, Colin, Alzouebi, Mymoona, Burlace, Barbara, Ferguson, Catherine, Hooton, Georgia, Jeffcutt, Nicole, Neal, Amy, Pezaro, Carmel, Sivoglo, Virgil, Taylor, Jennifer, Wilkinson, Nicola, Afzal, Naveed, Anderson, Beverley, Andrews, Stephen, Bakker, Piet, Breakspear, Sally, Cornaby, Andrew, Crellin, Perric, Gibbins, Andrew, Gibbins, Jackie, Glen, Tracy, Goodsell, Josie, Horton, Sarah, Love, Sally, Masters, Benjamin, Rees, Andrew, Sharpe, Simon, Taylor, Kate, Wignall, Suzy, Harrow, Sister Kath, Jones, Lesley, Kanyi, Karen, Keng-Koh, Pek, McGarry, Karen, Ramachandra, Prakash, Watts, Angela, Baumber, Shelley, Howard, Joanna, Jones-Skipper, Kay, Manetta, Caroline, McCrisken, Lauren, Taylor, Jo-Anne, Williams, Amanda, Clark, Alison, Clarke, Maria, Egan, Lisa, Fiddes, Kathleen, Forman, Susan, Gardiner, Fiona, Jeffrey, David, Mariappan, Param, Mayne, Barbara, McLaren, Duncan, Rogers, Brian, Woods, Catherine, Young, Douglas, Anderson, John, Baines, Kizzy, Crundwell, M, Davey, Elizabeth, Lawless, Theresa, Matkins, Ellen, McGinley, Shannon, McGrath, John, Piper, Jane, Roantree, Alison, Seath, Ingrid, Srinivasan, Rajaguru, Stott, Mark, Timmings, Katie, Webb, Claire, Al-hasso, Abdulla, Barwell, Lorraine, Dodds, David, Finnegan, Niall, Griffen, Ailsa, Jones, Rob, Lawless, Claire, MacMillan, Antonia, Russell, Martin, Sadozye, Azmat, Shirley, Sian, Sidek, Norma, Wallace, Jan, Akhtar, Naeem, Bell, Karen, Humpreys, Louise, McWilliam, Donna, Moody, Emma, O'Neil, Rebecca, Peck, Suzannah, Auladin, Raidah, Bird, Stephanie, Bissa, Caterina, Dabbs, Marianne, Di Maria, Fabio, Goh, Chee, Harding, Joshua, Jamieson, Ceri, Jones, Jules, Khaksar, Sara, Laing, Robert, Matthews, Laura, Medisetti, Aruna, Molony-Oates, Barbara, Money-Kyrle, Julian, Nobes, Jenny, Rabsztyn, Weronika, Sidi, Frances, Smale, Daisy May, Stone, Sarah, Tindall, Annie, Woods, Jane, Wu, Min, Daniel, Amelia, Holmes, Evelyn, Kellaway, Joanne, Lewis, Amanda, Light, Teresa, Melcher, Lucinda, Robinson, Lily, Staines, Nikki, Carini, Serrafina, Cooper, Sophie, Evans, Melanie, Follows, Josh, Grant, Warren, Hedges, Andy, Hughes, Claire, Jones (Birch), Janine, King, Lisa, Lees, Laura, Mercer, Lily, Myles, Sophie, Roberts, Zara, Williamson, Nicola, Abbassi, Sara, Alonzi, Roberto, Anyamene, Nicola, Bici, Julia, Collins, Lucy, Dickson, Jeanette, Garrido-Perez, Sandra, Hoskin, Peter, Hughes, Robert, Jenkins, Suzanne, Kowalewska, Paulina, Milner, Jessica, Mitchell, Lesley, Ostler, Peter, Rashid, Aamna, Stapleton, Stephanie, Bashir, Faheem, Bone, Linzi, Clark, Diane, Dixit, Sanjay, Horne, Rhian, Jones, Dawn, Palmer, Sarah, Plowman, Kristian, Rawlings, Julie, Simms, Matthew, Addison, Anglise, Arnott, Seonaid, Borgaonkar, Sudhir, Brown, Sandra, Campbell, Audrey, Colligan, Steve, Cormack, Margaret, Doughty, Victoria, Kelly, Kay, Lister, Debbie, Macdonald, Alison, Macgregor, Carol, Mackay, Rachel, Madeleine, Jude, McNally, Morag, McPhail, Neil, Neville, Sean, Nicholls, Alison, Papakostidi, Aristoula, Simpson, Georgina, Sinclair, Glenda, Skene, Anna, Telfer, Sheena, Urquhart, Zoe, Whillis, David, Etheridge, Charlotte, Ford, Amanda, Ridley, Paul, Scrase, Christopher, Upson, Susan, Venkitaraman, Ramachandran, Capaldi, Lisa, Churn, Mark, Higgins, Linda, Knott, Helen, Stringer (pr. Davis), Sally, Taylor, Jacob, Tranter, Helen, Wollaston, Julie, Brogan (nee Roddie), Stephanie, Erskine, Susan, Hamill, Maureen, Prentice, Lynn, Symon, Lesley, Teahan, Seamus, Todd, Anne, Tweedle, James, Young, Sally, Austin (nee Glover), Gemma, Boon, Ian, Bottomley, David, Breckin, Edmund, Clarke, Jude, Coyle, Catherine, Davies, Emily, Goulding, James, Kiltie, Anne, Loughrey, Carmel, Murad, Fatima, Pratt, Claire, Shuttleworth, Pam, Smith, Beccy, Smith, Gill, Branson (née Dineen), Amy, Christmas, Sallyanne, Cooke, Jill, Griffiths, Leyshon, Kent, Christopher, King, Amy, Kockelbergh, Roger, Potterton, Janet, Speed, Lesley, Vasanthan, Subramanian, Walker, Julia, Baria, Karin, Bateman, Samantha, Coombs, Sarah, Cunningham, Amy, Dahar, Nazeer, Daruwala, Pallon, Francis, Olesya, Hall, Jane, Hoare, Kathryn, Key, Claire, Lockwood, Carol, Mark, Ian, Newton, Rachel, Sloan, Andrew, Bermingham, Nicola, Dean, Lynsey, Malik, Zafar, Pilkington, Pauline, Robson, Peter, Rogers, Heather, Rogers, Thomas, Treherne, Katy, Bourke, Amie, Chikkamuniyappa, Bindu, Dalton-Short, Ross, Edwards, Steve, Falconer, Alison, Ford, Amy, Harinarayanan, Sathish, Hassan, Nebah, Hornzee, Gillian, Magwaro, Sophia, McInerney, Sue, Pratap, Bhavesh, Rezkallah, Sarah, Sadare (Olaleye), Ibiyemi, Stancliffe, May, Stewart, Simon, Thoi, Anne-Maree, Westrop, Anna, Ahamadali, Sheefa, Arsanious, Nasr, Balogun, Shaki, Batish, Cheryl, Campbell, Yvonne, Crowley, Claire, Dunne, Emma, Ferreira, Miguel, Haldeos, Anne, Hijab, Adham, Huddart, Robert, John, Babbin, Michaelidou, Andriana, Nawrozzadeh, Mohammed, Pach, Jackie, Patel, Priyanka, Payne, Ann, Perry, Matthew, Serra, Maria, Springall, Christine, Thompson, Jane, Thomson, Sister Jane, Tree, Alison, Aya, Viviana, Beaney, Ronald, Bower, Lorna, Conway, Lisa-Jane, Donaghey, Sally, Gordon, Hussain, Grau, Isabel, Harris, Sarah, Hogan, Vesna, Hore, Brendan, Hughes, Simon, Jones, Katie, Kuenzig, Greg, Morris, Stephen, Nunney, Dawn, Rashid, Jessica, Reynolds, Philip, Rooprai, Bali, Mangar, Stephen, Azirar, Hanna, Caumont, Tom, Gupta, Nishi, Hill, Judy, Karp, Stephen, Kullane, Sagal, Macavoy, Tina, Neave, Farhad, Newby, Jackie, Van Someren, Chloe, Anderson, Naomi, Annan, Lynda, Cooke, Juniebel, Douch, Emma, Fawcitt, Sara, Gore, Alexandra, Grieve, Sylvia, Jarvis, Claire, McCadden, Angela, Needleman, Sarah, Pigott, Katherine, Powell, Hannah, Ramtohul, Kaliyanee, Rosenfelder, Nicola, Vilarino-Varela, Maria, Ali, Jennyfa, Ali, Maryam, Banda, Laillah-Crystal, Bott, Trevor, Brown, Emmanuel, Bryant, Hanna, Carlino, Giulia, Grant, Cordelia, Hogan, Holly, Khoo, Vincent, Mojidra, Chintan, Montebello, Joseph, Morrison, Jennifer, Olabanji, Matthew, Pillai, Sijy, Siu, Bernard, Stafferton, Ruth, Storrs, Sarah, Townsend-Thorn, Debra, Van As, Nicholas, Vijayakumar, Vijitha, Welsh, Liam, Dearnaley, David, Gao, Annie, Horwich, Alan, Lewington, Val, Marshall, John, Murphy, Louise, Parker, Chris, Beaton, Kirsty, Bech-Nielsen, Nanette, Bolton, Olivia, Conibear, John, Dekaj, Fatjon, Hillman, Paul, Jayachandran, Resmi, Kaliski, Alexandre, Kiff, Janet, Nicholson, Alastair, Nixon, Jude, Oladimeji, Janet, Riches, Oscar, Smith, Dan, Tipples, Karen, Wells, Paula, Anderson, Chris, Daly, Deirdre, Dover, Serena, Gilmartin, Claire, Golden, Sophie, Gregg, Jane, Issa, Rami, Oni, Titilayo, Patel, Chandni, Quarrell, Mark, Rolfe, Debbie, Tighe, Helen, Toledo, Jesusa, Tuazon, Juel, Varro, Robert, Bohra, Vikram, Caballes, Mark, Custins, Laura, Ivie, Stephanie, Joshi, Manisha, Liau, Joy, Naim, Farhan, Patel, Anup, Pathmanathan, Byiravey, Russell, Emily, Tippins, Anna, Agdiran, Didem, Aggarwal, Ajay, Amoaten, Thomas, Aslam, Natasha, Bonsu, Nicole, Butt, Zainab, Danaswamy, Patricia, Davda, Reena, Gillesen, Annelies, Goel, Roshni, Khong, Rachel, Lowi, Suzy, Merrick, Richard, Mitra, Anita, Payne, Heather, Teh, Jonathan, Whinn, Samantha, Woolf, David, Zilkha, Helene, Dawson-Athey, Linda, Foster, Emma, Gillian, Andrew, Green, James, Hines, John, Holden, Simon, Kazingizi, Memory, O'Neill, John, Olaoni, Thompson, Peters, John, Philp, Timothy, Zaidi, Sadaf, Adeyoju, Adebanji, Adinkra, Victoria, Brough, Richard, Brown, Stephen CW, Collins, Gerald, Hardstaff, Lisa, Hill, Pippa, Kujawa, Magda, McCurrie, Marilyn, Townley, Barbara, Woodhouse, Iain, Zafar, Waheed, Beesley, Sharon, Breen, Vivienne, Burrage, Su, Calvert, Clare, Davison, Alison, Dias, Heather, Fossey, Gavin, Hotine, Jodie, Jones, Ifan, Jope, Carmel, Lines, Yvonne, Martins, Sarah, Mercier, Barbara, Murray, Jane, Neshiri, Innocent, Pamphlett, Ian, Phillips, Ann, Rai, Pavnish, Roberts, Verity, Taylor, Henry, Tribe, Lisa, Bottomley, Ian, Buchan, Jonathan, Carpio, Viviana, Choudhury, Ananya, Conroy, Ruth, Cowan, Richard, Davison, Sue, Duncan, Ian, Elliott, Tony, Fair, Kim, Fallaize, Adrian, Flanagan, Laura, Green, Sarah, Harris, Catherine, Hart, Amber, Jones, Cathryn, Livsey, Jacqueline, McCaul, Damian, Nazari, Roonak, Newbery, Carol, O'Connor, Kate, O'Dwyer, Sister Jackie, Oliver, Joanne, Onoge, Ekugbe, Petsa, Maria, Redshaw, Catherine, Smith, Sarah-Ellen, Spoor, Willemijn, Thomas, Sister Viv, White, Holly, Worsley, Lucy, Bailey, Linda, Bennett, Molly, Corless, Rebecca, Duffy, Annie, Fellows, Kathryn, Gipson, Anna, Haydock, Helen, Knox, WF, Liptrott, Sarah, McCarth, Fiona, McCartin, Fiona, Mistry, Heena, Mthethwa, Thobekile, Partington, Lillian, Piper, Lindsay, Ramani, Vijay, Sahin, Sarah, Sangar, Vijay, Slevin, Kathryn, Tuck, Jonathan, Atkinson, Lorraine, Barnbrooke, Sarah, Barnes, Alison, Brownless, Caroline, Chadwick, David, Hardman, John, Harland, Keith, Long, Carol, McAuliffe, Sarah, McBride, Julia, McClurey, Sister Patricia, Mohan, Rita, Naylor, Lynne, Peedell, Clive, Robson, Paula, Shakespeare, Devadasan, Thompson, Emma, Van der Voet, Hans, Wilson, David, Barron, Chris, Frew, John, Lambert, Katy, McMenemin, Rhona, Pedley, Ian, Riseborough, Danielle, Roberts, Trevor, Stockley, Emma, Stoddart, Jonathan, Tate, Janine, Walker, Jayashree, Workman, Bridget, Barnett, Debra, Carter, Adam, Cox, Adam, Davey, Alison, Davies, Kirstin, Gilby, Lisa, Hodge, Simon, Kearney, S, Lavender, Helene, Marty, Janet, Nash, Maxine, Rahman, Syhed, Richards, Jayne, Simpson, Julie, Wall, Elaine, Webb, Paula, Wild, Karen, Wilson, Jim, Branagan, Jenny, Dell, Gillian, Foo, Maxine, Goyena, Ruby, Jones, Andrea, McBain, Hazel, McGrath, Katherine, O'Callaghan, Jane, Ramanathan, Dorai, Tee, Elizabeth, Thominson, Bronwen, Tighe (nee Bussey), Rachel, Beety, Jane, Birch, Richard, Bloomfield, Mark, Callam, Sara, Cooper, Adele, Darby, Helen, Healey, Gail, Heasley, Karen, Kapur, Guarav, London, Clare, Oosterom, Katrien, Ostrowski, Joe, Shobrook, Bridget, Turner, Sarah, Wade, Rob, Walker, Suzanne, Walton, Sharon, Websdale, Cheryl, White, Joanna, Alder, Leanne, Chivers, Rachael, Gooch, Carol, Howard, Lucy, Hutchinson, Camille, Jevons, Cody, Kumar, Daniel, Marley, Hazel, Mills, Jamie, Purves, Hanna, Sayers, Ian, Sundar, Santhanam, Szolin-Jones, Jacob, Walker, Georgina, Wood, Catherine, Cook, Wendy, Gill, Lisa, Johnson, Joanne, Johnstone, Dawn, Jones, Richard, Mistry, Leena, Scarratt, Lyndsay, Aiku, Abimbola, Ajzensztejn, Daniel, Al-Chamali, Hiba, Andrade, Gerard, Barber, Dave, Bekulart, Sylwia, Bhatnagar, Gagan, Boutflower, Jane, Brewster, Simon, Butterfield, Anne, Carroll, Weronika, Cole, David J, Coutts, Tim, Doyle, Kerrie, Durrant, Lisa, Green, Trish, Jampana, Raj, Jastrzebska, Patrycja, Kyffin, Phillippa, Langridge, Nicole, Lawrey, Sarah, Markus, Sarah, Marston, Kerrie, Mooney, Matthew, Mukkath, Sandra, Murphy, Ann, Owens, Rob, Ruane, Sarah, Sabbagh, Ahmad, Samkange, Grace, Sankighatta, Naveen, Skwarski, Michael, Stuart, Robert, Wellman, Sandie, Wilson, Jo, Cavanagh, Kerrie, Hollingdale, Abigail, Allen, Susan, Barter, Elisa, Gregory, Debbie, Ingle, Charlotte, Lawrence, Steph, Rooney, Paula-Joanne, Bishop, Emma, Brennan, Maria, Cogley, Lyn, Hammonds, John Christopher, McInerney, Paul, McLarty, Esther, Natale, Salvatore, Pascoe, Sarah, Purcell, Keith, Sells, Henry, Tyner, Sharah, yates, Victoria, Beamish, Neal, Blaney, Hilary, Clapp, Felicity, Clarke, Elizabeth, Coffin, Teresa, Davies, Joe, Downs, Nichola, Gillespie, Sally, Heckford, Louise, Iskender, Amanda, Orford, Sara, Pressdee, Sandy, Rix, Sophie, Wheelwright, Roger, Woodward, Elizabeth, Wright, Seonaid, Blight, Kathy, Dobson, Tracey, Hale, Jennifer, Harris-Burland, Angie, Khoury, Ghassan, Madhava, Kudingila, Meadows, Lorna, Nagar, Yoodhvir, Roca, Mila, Stacey, Wendy, Stephenson, Anna, Uherek, Maja, Virgo, Azarel, Watkinson, Catrin, Birtle, Alison, Chauhan, Zainab, Cornthwaite, Stephanie, Curtis, Sandra, Ellard, Rose, Fish, Nathan, Hefferon, Billy, Searle, Claire, Spickett, Helen, Walmsley, Catherine, Atkinson, Jane, Brown, Richard B, Cartwright, Debbie, Coomber, Kristy, Hunt, Allison, Kowalczyk-Williams, Wioletta, Lewis, Christina, Parr, Stephen, Purdon, Helen, Rogers, Paul, Vowell, Emma, Featherstone, Wendy, Hamilton, Joanna, Harrison, Alison, Hindle, Margaret, Hodson, Hayley, Isaew, Andrea, Knapp, Jeanette, Moss, Sarah, Gibbs, Stephanie, Gujral, Sandeep, Jannapureddy, Revanth, Kelkar, Anand, Martinou, Maria, Mills-Baldock, Tina, O'Brien, Neale, Subramaniam, Ramachandran, Tahir, Saad, Vandal, Mohammad Tanvir, Vu, Thi, Allen, Rachael, Betts, Chris, Bowmer, Amanda, Clarke, Noel, Cordwell, Amanda, Dharmaprasad, Soney, Duncan (nee Keatley), Claire, Farnworth, Christine, Farrell, Helen, George, Siny, Goulden, Kay, Harter, Leah, Kaushal, Malan, Kirk, Sister Sarah, Lau, Maurice, Lydon, Anne Marie, O'Flynn, Kieran, Platt, Danielle, Shackley, David, Stevenson, Garry, Taylor, Sister Melanie, Thompson, Chloe-Anne, Vinod, Cellins, Wadsworth, Oliver, Youd, Sister Jill, Attlee, Julie, Bhatnagar, Adityanarayan, Bunn, Sarah, Campbell, Allister, El-Saghir, Mohammed, Fennelly, Ruth, Guy, Peter, Mattocks, Lehentha, Mcintosh, Gregor, Murphy, Brenda, Reed, Catherine, Strong-Sheldrake, Sophia, Tedd, Gemma, Dent, Kathleen, Hood, Marion, Martin, Karen, Pearson, Sandra, Potoczna, Dorota, Spencer, Sue, Towse, Jo, Whotton, Nikita, Bowen, Katie, Clark, Su, Clarke, Rachael, Gibbins, Kate, Martin, Jackie, Smith, Suzanne, Spalton, Catherine, Tay, Jessica, Adams, Marion, Bates, Emma, Chennattukungu, Indukala, Clancy, Joanna, Cross, Vanessa, Hughes, Hayley, Jose, Sanal, Kurian-Downer, Sunita, Michael, Elena, Moore, Sister Helen, Nicholas, Karen, Pope, Suzanne, Potts, Sally, Prashant, Ravi, Singh, Harpreet, Smith, Sandra, Srihari, Narayanan, Weaver, Emma, Abbas, Ali, Barnes, Nicky, Dallas, Nicola, Jackson, Sister Ann, Kader, Nicole, Karim, Omer, Laniado, M, Litchfield, Jayne, Mahmood, Sana, O'Donnell, Helen, Robinson, Victoria, Sears, Alison, Sharif, Shahid, Sierra Pala, Ana, Sinclair, Julie-Ann, Smith, Sister Catherine, Ashcroft, Jan, Boardman, John, Bowes-Cavanagh, Jeanette, Brown, Rebecca, Chedham, Alison, Darch, Flora, Farrar, Michelle, Foot, Jayne, Goldsworthy, Simon, Graham, John, Gray, Emma, Green, Sara, Jelski, Joseph, Kalejaiye, Odunayo, Keni, Manjusha, Locke, Angela, Mahoney, Sue, McMeekin, Faith, Periasamy, Manivannan, Russell, Tamlyn, Ruszala, Elizabeth, Segaran, Surayne, Tighe, Mary, Wallbutton, Rebecca, Webster, Christine, Whitcher, Alison, Wiggins, Sarah, Wrigley, Martha, Zietz, Maria, Abab, Julie, Cumming, Kirsty, Galloway, Lucy, Ganabady, Malavika, Haskell, Annelise, Heath, Catherine, James, Naomi, Kennedy, Julie, McFarlane, Victoria, Morales-Azofra, Fabiola, Morton, Susan, Mundy, Carina, Noble, Mark, Paschalis, Alec, Patrick, Julie, Reader, Leanne, Taylor, Lisa, Wakefield, Shauna, Ahmed, Imtiaz, Bowman, Sue, Chan, Olivia, Cyriac, Abby, Davies, Tracey, Maitland, Katrina, Prejbisz, Jan, Reece, Sheila, Shires, Heather, Tsang, David, Anscombe, Eleanor, Brough, WA, Clitheroe, Pat, Cocks, Tracie, Connolly nee McKenna, Sarah, Corcoran, Sam, Coughlan, Tricia, Gilmour, Christina, Goodwin, Emma, Graham, Susan, Hatimy, Umi, Hodgkinson, Sheila, Kilmartin, John, Orrell, Lucy, Rotherham, Carol, Smallwood, Sarah, Taylor, Jill, Wiss, Elliott, Adab, Fawzi, Bhana, Rajanee, Dhinakaran, Kathirvelu, Evans, Marion, Myatt, Alison, Parkinson, Katrina, Peake, Angela, Sellars, Elizabeth, Smith, Rowena, Storer, Julie, Thomasson, Georgia, Vengalil, Salil, Walton, Jenny, Ward, Angela, Boam, Samantha, Burgoyne, Jamie-Rae, Chadwick, Eliot, Gill, Shafiq, Haigh, Steve, Hollis, Keri, Lim, Jun, McCabe, Alastair, Munson, Lyndsey, Nash, Dominic, Saunders, Daniel, Smith, Susan, Wade, Lynne, Evans, Elizabeth, Franklin, Alex, Harris (n. Marchant), Emily, Johnstone, Maria, Jones, Lewis, Lemon, Nicola, Phan, Mau-Don, Pudney, Delia, Spence, Rachael, Stretch, Alison, Tait, Ellen, Williams, Bethan, Belcher, Rebecca, De Silva-Minor, Shiroma, Dodge, Sister Jan, Grayland, Sarah, Jones, Ania, Khan, Omar, Owen, Tim, Palmer, Debbie, Parajes, Cerila, Pegler, Suzannah, Poole, Abbie, Sargent, Sister Tracey, Starling, Ellen, Taylor, Becky, Winter, Sister Helen, Zinyemba, Vivian, Allison, Michele, Blundell, Martyn, Brookman, Catherine, Buckley, Jon, Chamberlain, Shelley, Cuffe, Donna, Davies, Stacey, Fairfax, Claire, Greedus, Helen, Griffin, Hannah, Koehler, Ingrid, Lydon, Anna, Michels, Jorg, Pym, Julia, Roberts, Fiona, Thornton, Lorraine, Vandecandalaere, Elaine, Watts, Erica, Welsh, Linda, Anderson, Jim, Anderson, Juliette, Ball, Julie, Benton, Louise, Bowers, Richard, Chahal, Rohit, Dickinson, Peter, Fosker, Chris, Heeley, Janine, Kanaga-Sundaram, Subramanian, Littler, Stephen, Slack, Jonathan, Sundaram, Subramanian Kanaga, Taylor, Beverley, Weston, Philip, Chettle, Judith, Hartwell, Lyn, Johnson-Rollings, Ashley, Jones, Julia, Millage, Helen, O'Neill, Eilish, Walsh, Donna, Webb, Kerrie, Williams, Jo, Dymond, Harvey, Eleftheriadis, Symeon, Lloyd-Jones, Hugh, Wells, Tom, Bennett, Sarah, Dunn, Sharon, Fildes, Diane, Hassall, Alison, Herbert, Gaynor, Hughes, Kathryn, Innes, Helen, Kelly, Alison, Littler, John, Lomax, Laurie, Miller, Nikki, Nutman, Chris, Stott, Matthew, Syndikus, Isabel, Tolan, Shaun, Weston, Alison, Baker, Ivanna, Carter, Vanda, Chatfield, Jenny, Cooke, Peter, Grant, Anna, Homer, David, Kirk, Christine, Lomas, Claire, McCormick, Marian, Mohseeni, Arizoo, Pawaroo, Renita, Radford, Liz, Rogers, Jason, Samanci, Ali, Sharman, Emma, Spencer, Hazel, Spruce, Debbie, Worthington, Hannah, Bak, Dagmara, Cleary, Kristy, Davies, Sue, Gauntlett, Monica, Gupta, Kamalnayan, Holdsworth, Amanda, Ledger, Kate, Morrow, Hugh, Perry, Heather, Rimell, Patricia, Rosoman, Alison, Tyler, Jayne, White, Ann, Crowe (nee Hughes), Dawn, Flynn-Batham, Marian, Folkes, Linda, Funnell, Sarah, Gilbert, Jeanette, Gomez-Marcos, Raquel, Gonzalez, Celia, Hoskins, Chloe, Moore, Sally, Plataniotis, George, Rippin, Sarah, Smith, Matthew, Tsawayo, Tan, Turner, Nikki, Wakelen, Paula, Cserbane, Anita, Fernandez, Claire, Kurup, Rahul, Manyangadze, Sarah, McLain-Smith, Susan, Protheroe, Andrew, Trewsmith, Neil, Allison, Joanna, Barron, Claire, Beaumont, Erica, Beer, Nigel, Beesley, Kate, Donaldson, David, Duckett, Tracey, Fox, Shirley, Kotze, Michelle, Kumar, Shiyam, Macrory, Joanne, Perry, Jess, Pippard, Lucy, Porter, Tim, Rennie, Kerry, Sparrow, Geoffrey, Williams-Yesson, Barbara, Balderson, Jane, Bowling, Lorna, Brittain, Paul, Brookes, Claire, Campbell, Hilary, Campos, Monica, Conway, Rachel, Davies, Flor, Donnison, Michelle, Elliott, Mark, Evans, Richard, Fallah, Fereshteh, Fearnley, Mark, Giddings, Emma, Gollapothu, Srilakshmi, Harvey, Sally, Holbrook, Andy, Ingham, Jo, Jakeman, Christine, Joseph, Joji, Mole, Lisa, Musunuru, Hima Bindu, Pashley, Sarah, Saleem, Shamila, Stower, Michael, Strider, Paula, Taylor, Carol, Thackray, Louis, Todd, Joanna, Wightman, John, Wilson, Russ, Youngs, Nora, Byrne, Mary Marg, Deenihan, Emma, Durkan, Garret, Jennings, Marian, Mahoney, Catriona, Martin, Joseph, McInerney, Veronica, Raftery, Liz, Rogers, Eamonn, Spillane, Maria, Sullivan, Frank, Teh, Chiaw Woon, Wright, Ann, Harving, Niels, Hejlesen, Finn, Kempel, Mette Moe, Steffensen, Kirsten, Bentzen, Lise, Borre, Michael, Buus, Simon, Fode, Kirsten, Kaa Bach, Birgit, Lassen, Yasmin, Laursen, Vibeke, Lemng Kruse, Helle, Lucakova, Slavka, Nørmark Iversen, Helle, Brasso, Klaus, Christensen, Anne Juel, Gruschy, Lisa, Klovgaard, Karina, Lunau, Anne Sofie, Meidhal Petersen, Peter, Moller Christensen, Trine, Poder, Lone Lund, Ribers, Kristine, Stilling, Sine, Thim, Stine, Torin Lehmann, Anna, Vandborg, Maria, Christensen, Tine, Kokholm, Kathrine Friser, Lindberg, Henriette, Nybom, Kirstine, Rønnengart, Eva, Saxe, Charlotte, Baird, Noelle, Braun, Michael W, Cheung, Arthur, Fourt, Monica, Jackson, Cathy, Jepson, Debbie, Johnson, Arlissa, Karvat, Anand, Kwan, Winkle, McIndoe, Sue, Mitchell, Donna, Sandhu, Sandeep, Serpanchy, Rosanne, Wu, Helen, Beausoleil, Rachelle, Crawford, Melanie, DiMarco, Christine, Ding, Ian, Gladwish, Adam, MacIsaac, Patricia, MarshGray, Kimberley, Morton, Gerard, Murphy, Cara, Pascoe, Caitlin, Pokhrel, Sujata, Stevens, Christiaan, Yoon, Frederick, Yu, Jason, Dubey, Arbind, Sivananthan, Gokulan, Bahary, JeanPaul, Barkati, Maroie, Beauchemin, MarieClaude, Benth, Silvine, Carbonaro, Adriana, Delouya, Guila, ElSokhn, Nidale, Frazzi, Alexandra, Lambert, Carole, Lavertu, Sophie, Menard, Cynthia, Pan, Siew Siew, Rousseau, Pierre, Saad, Fred, Taussky, Daniel, Trudel, Diane, Amanie, John Oliver, Batz, Margaret, Borynec, Carol, Danielson, Brita, Garcia, Leni Santiago, Gramlich, Colin, Lang, Monika, Larson, Beverly, Mallett, Debbie, McCrudden, Sylvia, Murtha, Albert, Parker, Shelley, Parliament, Matthew B, Patel, Samir, Pearcey, Robert, Pervez, Nadeem, Rose, Jim, Shewchuk, Caroline, Smith, Carlie, Usmani, Nawaid, Williams, Candra, Yee, Don, AlRashdan, Abdulla, Avery, Alison, Beaton, Heather, Bond, Brittany, BrucePayne, Kim, Burbridge, Susan, Bursey, Kara, Carvery, Lane, Dill, Kendra, Dugas, Stevie, Harding, Claudia, Hodder, June, Hollenhorst, Helmut, Hubley, Lynn, Joseph, Paul K, Little, Erin, MacDonald, Angela, MacIsaac, Kathy, MacVicar, Jennifer, McCracken, Jillian, Moffatt, Emily, Nieforth, Joan, Patil, Nikhilesh, Rijt, Kelsey van der, Roberts, Victoria, Rose, Tina, Rutledge, Robert DH, Salyzyn, Camryn, Simpson, Robin, Sutherland, Donna, Walker, Heather, Wilke, Derek, Yeo, Tanya, Yunace, Lorrie, Zinck, Connie, Bier, Bianca, Bucci, Catherine, Corbett, Thomas B, Dayes, Ian S, Eady, Robin, Gudelis, Susan O, Hill, Elaine, Kinrade, Yvonne, Laughlin, Anne, Lukka, Himu, Makepeace, Barbara, Marshall, Lynn, Nielsen, Linda, Oliverio, Carmela, Patel, Malti Behn, Tsakirdis, Thedoros, Wong, Jason W T, Allen, Kirsten, Bachand, Francois, Carefoot, Layton, Cotts, Shannon, Creelman, Brianna, Crook, Juanita, GeorgeChayka, Danielle, Halperin, Ross, Hartt, Nancy, Hayes, Jill A, Kim, David, Kim, TuongVan, Kronstal, Flo, Lee, Bernard, Lew, Tanya, McClelland, Marie, Opitz, Debbie, Overend, Aldyn, Reed, Melanie, Watson, Michaella, Wilkie, Karen, Winn, Carol, Yanchuk, Janet, Bonner, Scott, Brander, Mike, Brundage, Michael, Carlson, Cindy, Edwards, Jackie, ElKerdawy, Hala, Harpell, Rhonda, Hartman, Carrie, Kalyvas, Maria, KirbyBello, Denise, Kumar, Vikaash, Leach, Deborah, MacVicar, Karen, Mahmud, Aamer, Maize, Christine, Moelker, Yvonne, Murano, Abby, Paul, Nancy, Ross, Ashley, RossSmith, Marleen, Shenfield, Carey, Spencer, Craig, Tennant, Virginia, Vermette, Tracy, Willing, Stephanie, Zaza, Khaled O, Zeltser, Fred, Gearing, Jennifer, Girolametto, Carla, Gopaul, Darindra, Hamilton, Ronald, Hendel, Debra, Janke, Susan, Knackstedt, Jochen, Kuk, Joda, Morrison, MaryBeth, Mumin, Anissa, Nemirov, Stephanie, Rachakonda, Ramana, Shantz, Brenda S, Siddiqui, Atif, Thallury, Sheeba, Ahmad, Belal, Bailey, Laura, Bauman, Glenn, Camara, Mary Jane, Corkery, Danylle, DSouza, David, DiLullo, Elenor, Eichenberger, Lois, Francis, Peggy, Grant, Susan, Gratton, Albert, Gurzanski, Christina, Hare, Jennifer A, Johnson, Craig, Kenny, Shannon, Lock, Michael I, Loughlin, Kate, Mardell, Stephen, Mayer, Heather, Rodrigues, George B, Sax, Lori, Sebborn, Kes, Sexton, Tracy, Venkatesan, Varagur M, tenHaaf, Darlene, Chatelain, AnneMarie, Fortin, Jacqueline, Houle, Stefanie, Khaouam, Nader, Lachance, Nicole, Laliberte, Benoit, Lemaire, Celine, Nguyen, David H A, Sylvestre, Alma, Vavassis, Peter, Yassa, Michael, Adnaan, Jamila, Briand, Wayne, Casey, Linda, Chipman, Penny, Corwin, Charlotte, Duclos, Marie, Faria, Sergio Luiz, Ghoul, Mokhtar, Joncas, MarieClaude, Koulouris, Zoe, Larocque, Stephanie, Lee, Brenda, Olha, Carolynna, Robert, MarieFrance, Sharma, Rajesh, Shenouda, George, Souhami, Luis, Albrecht, Virginia, Froese, Jane, Froude, Nancy, Howitt, Pamela, Iqbal, Fawaad, Kift, Shannon, Koll, Wayne, Li, Audrey, MacGregor, Barbara, Manganaro, Aileen, McKee, Dianne, Mendoza, Edeliza, Mui, Jimmy, Myrehaug, Sten, Singson, Angelina, Slessor, Janet, Somasiri, Ashane, Stevens, Nicole, Berghout, Koralee, Bourque, JeanMarc, Carkner, Amy, E, Choan, Eapen, Libni, Eze, Nancy, Fish, Matt, Haddad, Alain, Hicks, Kimberly, Iordanidi, Elina, Kanji, Femina, Kendal, Wayne S, MacMullin, Lisa, MacRae, Robert M, Malone, Shawn, Morgan, Scott, Nguyen, Julie, OBrien, Anna, Page, Nancy, Perry, Gad A, Reeves, MarieClaude, Roach, Joanne, Sanchez, Maria, Spearman, Mary, Spencer, Patti, Tikoo, Archana, Turriff, Lisa, Wright, Natalie, Bedoya, Luis Diaz de, Cossette, Danielle, Cusan, Leonello, Desrosiers, Isabelle, Dufour, Nathalie, Foster, William, Gomez, JoseLuis, Hathout, Lara, Lajoie, MarieAndree, Martin, AndreGuy, Pouliot, Sophie, Vigneault, Eric, Bouchard, Myriam, Bujold, Rachel, Carmel, Michel, Cote, Genevieve, Dion, Helene, Ebacher, Annie, Gauthier, Isabelle C, Ladouceur, Cynthia, Lamoureux, Alexandra, Larouche, Julie, Marquis, Tania, Nabid, Abdenour, Pearson, Diane, Sabbagh, Robert, TetreaultLaflamme, Audrey, Baker, Erin, Blackwood, Geoffrey, Galway, Denise, Greenland, Jonathan, Hannaford, Zeta, Hoskins, Ashley, House, Gail, Kamran, Asim, Manning, Kimberley, Nelder, Matthew, Noel, Lorilee, Norman, Alia, ODea, Jamie, Pinnell, Erin, Pochini, Craig, Putt, Dawne, Rahman, Arifur, Rickert, Lauren, Sathya, Jinka R, Teasdale, Breanne, Thoms, John, Whiteway, Chrystal, Whittle, Stacy, Cheung, Patrick CF, Chu, William, Chung, Hans T, Commisso, Angela, Danjoux, Cyril, Escueta, Vivette, Klotz, Laurence, Leung, Michael, Liu, Stanley, Loblaw, Douglas Andrew, Malek, Leila, Nam, Robert K, Szumacher, Ewa, Tseng, Eric Chia Lin, Vesprini, Danny, Abed, Jessy, Ang, Daniel, Bayley, Andrew J, Berlin, Alejandro, Bristow, Robert, Catton, Charles, Chan, Heidi, Chui, Amadeus, Chung, Peter, Degendorfer, Sarah, Gospodarowicz, Mary, Gregorcic, Emily, Gumapac, Nicole, Helou, Joelle, Hsien, John, Kong, Vickie, Lalani, Nafisha, Lao, Bernadeth, Lawson, Daeria, Merante, Pat, Milosevic, Michael, Mirmooji, Ramesh, Muraj, Zaynab, Peres, Sarin, Petroff, Avi, Petrovska, Aleksandra, Pineda, Sandra, Quintos, Judy, Raman, Srinivas, Ramotar, Sarah, Ruiz, Maria Jose Gaitan, Sabate, Kathryn, Shukla, Arundhati, Tharahan, Nanthini, Thevarajah, Vaishaali, Tiessen, Kyoko, Topalovich, Aleksandra, Torres, Cynthia, Tse, Karen, Tsuji, Debbie, Velec, Erin, Wallace, Kris, Warde, Padraig, Bisson, MarieEve, Dahmane, Rafika, Gagne, Vanessa, Harvey, Julie, Lebrun, Benoit, Marineau, Line, Montour, Julie, Samson, Julie, Sicard, MarieEve, Thibeault, Andreanne, Vincent, Francois, Vincent, LindaSuzanne, Blood, Paul A, Canavan, Joycelin, Clements, Mia AnnaMaria, Glick, Daniel, Holloway, Caroline, Holwerda, Eleanor, Joe, Howard, Lacey, Cathy, Lam, Jacqueline, Leong, Nelson, Lim, Jan, Lomas, Alia, Pai, Howard H, Priestley, Emilie, Shahid, Negin, Vallieres, Isabelle, Duncan, Graeme, Gleave, Martin E, Goldenberg, S Larry, Karunakaran, Subashini, Keyes, Mira, KimSing, Charmaine, McKenzie, Michael, Morris, William James, Nakashima, Lynne, Peacock, Michael, Pickles, Thomas A, Sibug, Sheena, So, Alan I, Tyldesley, Scott, Zhang, Tina Wanting, Ahmed, Shahida, Ammeter, Barb, Anderson, Leanne, Ann, Taehee, Bakija, Zeljka, Bashir, Bashir, Benjaminson, Patricia, Bergen, Leah, Cadiz, Lovely, Chahine, Jacqueline, Cherepak, Kathy, Chornopyski, Tracy, Chowdhury, Amitava D, Davies, Heather, Dawe, David, Drachenberg, Darrel E, DuMontier, Joelle, Eska, Tiffani, Francisco, Cristina, Gamez, Raquel, Garrett, Gina, Giovannini, Julia, Graham, Jeffrey, Guarino, Robyn, Hunter, William, Johnston, Laurel, Kitkowski, Caitlin, Klapp, Kathi, Koul, Rashmi, Kuzyk, Valerie, Last, Debbie, Li, KuanLin, Long, Heather, Majumdar, Arpita, Marek, Kathleen, McNish, Jennifer, Mills, Laurie, Morales, Maria, Nashed, Maged, Nichol, Rhonda, Ong, Aldrich Dixon, Ouelette, Ashley, Patel, DeepKumar, Pawl, Marilyn, Peak, Lisa, Priebe, Shauna, Quon, Harvey, Rizzuto, Stacey, Rudnicki, Rayleen, Santos, Priscilla, Sharma, Atul, Squires, Mandy, Trakalo, Kathy, Turner, Christy, Vaughn, Jamie, Walker, Lori, Watson, Melanie R, Wei, Joyce, Weir, JoAnn, Woloshyn, Rose, Wood, Allison, Zhang, Hanbo, Zwarych, Darlene, Parker, Chris C, Cook, Adrian D, Clarke, Noel W, Catton, Charles N, Cross, William R, Petersen, Peter M, Persad, Rajendra A, Pugh, Cheryl A, Bower, Lorna C, Bottomley, David M, Chung, Peter W M, Ford, Vicky, Goh, Chee L, Heath, Catherine M, James, Nicholas D, Kim-Sing, Charmaine, Kodavatiganti, Ravi, Malone, Shawn C, Morris, Stephen L, Ong, Aldrich D, Parulekar, Wendy R, Parmar, Mahesh K B, and Sydes, Matthew R
- Published
- 2024
- Full Text
- View/download PDF
8. Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial
- Author
-
Amos, Claire, Beaney, Katherine, Bellenger, Katharine, Brawley, Chris, Chung, Christina, Cook, Adrian, Embleton, Andrew, Forcat, Silvia, Goldstein, Cindy, Grabey, Jenna, Hague, Dominic, Herasimtschuk, Anna, Islam, Zaheer, Jovic, Gordana, Maniatis, Christos, Masters, Lindsey, Mohamed, Fatima, Morgan, Rachel, Murphy, Claire, Noor, Dipa, Parmar, Max, Patterson, Paul, Pickering, Holly, Pugh, Cheryl, Rauchenberger, Mary, Ribeiro, Helena, Roach, Carol, Seray-Wurie, Fatimah, Shaji, Preetha, Sims, Hannah, Spittle, Ben, Sydes, Matthew, Tappenden, Nancy, Tsang, Lilian, Uscinska, Barbara, Brown, Teddy, Casey, Sue, Davidson, Cathy, Dellar, Conor, Fletcher, Mandy, Meyer, Ralph, Murphy, Karen, Parulekar, Wendy, Richardson, Harriet, Richardson, Karen, Whelan, Kate, Bissett, Donald, Bonner-Shand, Shelagh, Grant, Judith, Lynch, Rory, MacDonald, Graham, McWilliam, Marie, Moir, Rachel, Rodwell, Sue, Shearer, Kirsty, Smith, Margaret, Binns, Louise, Briggs, Maxine, Brown, Simon, Casanova, Nathalie, Clark, Katy, Hartley, Jasmine, Henry, Ann, Henson, Helen, Hill, Pipa, Jeyasanger, Ganesan, McAlister, Judy, Parkinson, Sharron, Shaw, Alison, Alcock, Christopher, Brady, Joanne, Camilleri, Philip, Carpenter, Janice, Hogbin, Emma, Hyde, Katherine, Kavanagh, Roisin, Ngumo, Alice, Padilla-Harris, Cheryl, Panakis, Niki, Pwint, Thinn, Sabharwal, Ami, Stammers, Tracey, Stone, Helena, Varley, Gail, Weaver, Andrew, Wynn, Hazel, Allan, Elaine, Ansari, Jawaher, Cannon, Philip, Carruthers, Ross, Coubrough, Claudia, Cowan, Chloe, Glen, Hilary, Graham, Janet, Hardie, Maryon, Love, Clare, Macleod, Nicholas, Mahmood, Rana, McClements, Jane, McGlynn, Brian, McKernan, Margaret, Mcleod, Nick, Othman, Aqilah, Ross, Kristy, Roxburgh, Patricia, Templeton, Maureen, Tufail, Aisha, Turley, Claudia, Wilson, Mark, Ali, Zulfiqer, Andrews, Kelly, Burns, Rebecca, Butterworth, Caryl, Coventry, Thomas, Evans, Angela, Jones, Gareth, Lewis, Sion, Oommen, Nikhil, Owen, Susan, Saxton, Wendy, Tapping, Sister Hayley, Thomas, Dianne, Thomas, Rachel, Walker, Beth, Williams, Rachel, Collard, Susan, Ford, Victoria, Goodhind, Frances, Holbrook, Becky, Kershaw, Elizabeth, Ley, Samantha, Martinez, Maria, McCormack, Anne, Sheehan, Denise, Toy, Elizabeth, Van-Koutrik, Lynne, Varughese, Mohini, Aitken, Katherine, Barlow, David, Beattie, Louise, Bownie-Mukumbu, Godfrey, Bryan, Rachel, Corner, Victoria, Edwards, Abigail, Fazekasne Fulep, Adrienn, Guerrero-Urbano, Teresa, Gwilt, Julie, Happle, Liz, Jackman, Dee, Krysta, Beata, Paisey, Sangeeta, Shaffer, Richard, Smith, Jackie, Westley, Rosalyne, Yusof, Hilawati, Appleby, Rowan, Avis, Joanne, Beresford, Mark, Brydon-Hill, Ruth, Cox, Christine, Curtis, Samantha, Elwell, Christine, Frim, Olivera, Hamilton, Beatrice, Hudson, Zoe, Jenner, Abigail, Mantle, Mark, Mason, Jessica, Masson, Susan, McFarlane, Jonathan, Newman, Hugh, Pocock, Abigail, Robertson, Bryony, Tomlinson, Eve, Wassall, Rebecca, Williams (Née Allen), Sister Tania, Brown, Grace, Clarke, Peter, Cole, Aiden, Cousins, Jane, Gilchrist, Gail, Hagan, Chris, Hanna, Emma, Harney, Jackie, Hetherington, Stacey, Houghton, Fionnuala, Hynds, Sharon, Jain, Suneil, Johnston, Ruth, Keane, Patrick, Lyons, Ciara, McAleese, Jonathan, McAllister, Jo, McKenna, Karen, Mitchell, Darren, Murray, Stacey, O'Sullivan, Joe, Rajan, Nambi, Shum, Poh Lin, Stewart, David, Stranex, Stephen, Totten, Grace, Chandrashekara, Madhura, Drew, Ellen, Drew, Mary (Ellen), Fletcher, Julie, Gamble, Tina, Lokes, Rachel, Schumacher, Ann, Shetty, Kavitha, Sohanpal, Sundip, Whitehouse, James, Zarkar, Anjali, Ford, Daniel, Glaholm, John, Lenton, Daniel, O'Beney, Rachael, Taylor, Helen, Thomas, Helen, Chetiyawardana, Samantha, Doherty, A, El-Modir, Ahmed, Gunn, Melanie, James, Nicholas, Kedge, Liz, Mannan, Aliyah, Marange, Josephine, Morrison, Andrew, Okubanjo, Maryanne, Olaniyi-Oduntan, Darlletta, Peterkin, Zhane, Preece, George, Qureshi, Zayn, Ross, Liliam, Samra, Tarandip, Southgate, Elizabeth, Stephens, Rebekah, Stevenson, Robert, Watson-Jones, Phillip, Abdulwahid, Danya, Ainsworth, Sarah, Ashworth, Sue, Beard, Karen, Charnley, Natalie, Desai, Parth, Fielding, Bethany, Flaherty, Jan, Forrest, Diane, Frankland, Helen, Haidar, Imran, Hargreaves, Jeanette, Henry, Joanne, Hugill, Angela, Jewers, Karen, Keith, Sarah, Kilroy, Stephen, King, Jennifer, Parikh, Omi, Riley, Karen, Ryan-Smith, Janet, Thomas, Jacqueline, Thompson, Catherine, Tickle, Vivienne, Waring, Lynsey, Wise, Marcus, Dawson, Louise, Ditchfield, Julie, Al-Samarraie, Amir, Bolger, Annette, Davies, Llinos, Flavin, Aileen, Heron, Jane, Hughes, Faye, Jackson, Kim, Lewis, Joanne, Manley, Rachel, Rutter, Charley-Anne, Smith, Nick, Srinivasan, Vaiku, Stockport, Jane, Thomas, Heather, Toussi, H, Wood, Cathryn, Archer, Simon, Fletcher, Joanne, Ginnelly, Helen, Kirkby, Amy, Knight (n. Sherburn), Victoria, Lawrence nee Palmer, Tara, Mashegede, Beverley, Metcalf, Karen, Panades, Miguel, Sreenivasan, Thiagarajan, Szymiczek, Kinga, Thomas, Isobel, Young, Anita, Broadley, Eve, Brock, Sue, Davies, Joseph, Jones, Stephanie, McCully, Ruby, Naraine, Nicky, Preece, Kate, Purandare, Laura, Rabbi, Taslima, Savage, Sarah, Vamplew, Luke, Bamford, Linda, Benton, Richard, Cotterill, Lauren, Inman, Hayley, Karsera, Louise, Kay, Anne Marie, Kenyon, Lucille, Lazarte, Jannika, McNulty, Dawn, Moore, Eleanor, Nallathambi, Chandran, Naylor, Deirdre, Owen, Lisa, Parikh, Shefali, Pendrill, Amy, Price, Joanne, Robertshaw, Helen, Rodda, Sree, Sewell, Jane, Teo, Mark, Waldron, Eleanor, Bloomfield, David, Blythe, Tracy, Brown, Joanne, Carr, Philippa, Chambers, Carla, Dlodlo, Jessica, Frattaroli, Paul, Gilbert, Duncan, Hart, Andrew, Hodges, Samantha, Hooper, Simon, Hunter, Catherine, Lactao, Ranee, Leitao, Madalena, McKinna, Fiona, Nikapota, Ashok, Peterson, Jane, Robinson, Angus, Tremlett, Jean, Webb, Andrew, Wilkins, Marie, Young, Bobbie, Bahl, Amit, Baxter, Matt, Bowers, Dawn, Challipalli, Amarnath, Coe, Marc, Cowley, Sue, Gillatt, David, Griffiths, Dorothy, Henson (nee Savidge), Verity, Hilman, Serena, Hollister, Robert, Kisanga, Mary, Lee, Vivienne, Lowe, Amelia, Macefield, Rhiannon, Pegler, Ruth, Robertson, Peter, Saldanha, Helen, Simmonds, Mary, Sims, Laura, Wheeler, Lucie, Wilson, Paula, Woods, Martin, Yarrow, Sue, Zelley, Sarah, Abd Alazeez, Mohamed, Alderton, Kate, Brain, Carol, Chilcott, Helen, Clarke, Samantha, Cobos-Arrivabene, Marta, Corderoy, Helen, Cousins, Rebecca, Garner, Victoria, Herbert, Chris, Johnson, Lyndsey, Jones, Kathryn, Kemp, Gail, Kirkby, Sarah, Kirkpatrick, Suriya, Koupparis, Anthony, Manning, Courtney, Oxley, Jon, Perry, Emily, Persad, Raj, Phipps, Charlotte, Richmond-Russell, Kerry, Rowe, Edward, Shelton, Luke, Shiridzinomwa, Constance, Smith, Carolyn, Treasure, Ann, Wyatt, Clare, Beesley, Katherine, Benson, Richard, Couch, Ellie, Foxwell, Sue, Goss, Vanessa, Harnwell, Juliette, Hughes-Davies, Luke, Joslin, Vicky, Laubscher, Angelique, Mazhar, Danish, Patterson, Helen, Raj, Sanjay, Ramanujachar, Ramya, Rimmer, Yvonne, Robinson, Nicola, Russell, Simon, Stone, Matthew, Thomas, Robert, Treeby, Jo, Vickery, Kathryn, Woodward, Cathryn, Ahmed, Ilyas, Appleby, Bonny, Brulinski, Patryk, Buckley, Julie, Catt, Natalie, Coppins, Helen, Crawford, Sister Denise, Davies, Julie-Ann, Drakeley, Susan, Edwards, Albert, Evans, Clary, Galante, Joao, Gladwell, Louise, Gough, Jessica, Hargreaves, Carolyn, Hegarty, Gemma, Kehoe, Laura, Larkins, Rachel, Lipsham, Margaret, Little, Jessica, Malde, Rohit, Middleton, Sharon, Mikropoulos, Christos, Mirza, Arafat, Mithal, Natasha, Nathan, Kannon, Raman, Rakesh, Rendall, Alice, Robinson, Karen, Ryan, Rachel, Sim, Van, Swann, Michelle, Tasker, Lorraine, Taylor, Katy, Thomas, Carys, Trigonis, Ioannis, Walker, Karen, Williams, Joanne, Williamson, Elizabeth, Wood, Marian, Wood, Pauline, Zurakovsky, Hilary, Bois (nee Harris), Elizabeth, Chan, Hin Fan, Chikopela, Loveness, Clark, Helen, Clements, Colette, Holliday, Samantha, Hughes, Owen, Jones, Clare, Kynaston, Howard, Mason, Malcolm, Narahari, Krishna, Pearse, Kevin, Staffurth, John, Austin, Mandy, Barnett, Christian, Camburn, Sister Tracey, Dawson, Elizabeth, Gibson, Sian, Hamid, Abdel, Kancherla, Kiran, Leone, Priscilla, Perkins, Lauren, Ramsay, Valerie, Singizi, Bryan, Allen, Julie, Anderson, Susan, Andrews (nee Moore), Eleanor, Bakawala, Rehana, Beazer, Sarah, Binks, Colin, Bowen, Jo, Broomfield, Barbara, Cook, Audrey, Crossley, Lin, Ford, Chris, Forkes, Janet, Hall, Julia, Healey-Mariano, Jennifer, Jenkins, Peter, Johnson, Nigel, Jonnada, Sai, Owen, Roger, Pratten, Elaine, Sayers, Rachel, Shimell, Chris, Skelton, Amy, Tan, Matthew, Trigg-Hogarth, Kate, Wronski, Sue, Aldous, Mary, Archer, Denise, Eccleson, Helen, Gallimore, Elizabeth, Green, Sue, Ibrahim, Azman, Jones, Carys, Prince, Jude, Chrystal, Melanie, Din, Omar, Firth, Alexandra, Ford, Nicky, Kirkbride, Peter, Martindale, John, Redfearn, Alison, Smedley (nee McCabe), Janine, Smith, Lucy, Sorice, Vittoria, Stevenson, Lesley, Toms, Julie, Wood, Sister Kim, Barke, Nyssa, Basu, Devy, Dewar, Lorna, Driscoll, Celine, Hunting, Liz, Kumar, Muthar, Mabelin, Louies, Sizer, Bruce, Thorogood, Lucy, Askew, Sarah, Beech, Darren, Broom, Jane, Duley, Emma, Firth, Elizabeth, Gould, Aaron, Hocking, Christopher, Johns, Louise, Kent, Emma, Madine, John, Partridge, Kerena, Penhaligon, Corrine, Pentecost, Catherine, Pollard, Kay, Poultney, Melissa, Pynsent, William, Skewes, Johanna, Steele, Anita, Thomson, Alastair H, Topps, Alice, Townley, Luke, Wheatley, Duncan, Brown, Maggie, Chan, Andrew, Connor, Marie, Elwell, Sue, Geraghty, Kerry, Griffiths, Theresa, Hayward, Lesley, Humber, Caroline, Khan, Yakhub, Lake, Sister Judith, Laverick, Rosaleen, Mansell, Gemma, Mislang, Albert, Ngwenya, Su, Panesar, Pritpal, Sanders, Kay, Simmons, Elaine, Sinfield, Melanie, Stanley, Laura, Steventon, Emily, Stockdale, Andrew, Sunny, Manju, Thind, Manreet, Tranter, Fiona, Tsalic, Medy, Worlding, Jane, Adamson, Vanessa, Bennion, Carole, Butler-Barnes, Jenny, Hough, Adele, Hough, Chris, Hughes, Joanne, Irwin, P, Javle, P, Logue, John, Mansfield, Carolyn, Smith, Rachel, Sumner, Lesley, Tomlinson, Annabel, Tran, Anna, Walker, Caroline, Wylie, James, Chakraborti, Prabir, Das, Prantik, Ennis, Dawn, Marriott, Sue, Muthukumar, Dakshinamoorthy, Pattu, Pugazhenthi, Ward, Colin, Alzouebi, Mymoona, Burlace, Barbara, Ferguson, Catherine, Hooton, Georgia, Jeffcutt, Nicole, Neal, Amy, Pezaro, Carmel, Sivoglo, Virgil, Taylor, Jennifer, Wilkinson, Nicola, Afzal, Naveed, Anderson, Beverley, Andrews, Stephen, Bakker, Piet, Breakspear, Sally, Cornaby, Andrew, Crellin, Perric, Gibbins, Andrew, Gibbins, Jackie, Glen, Tracy, Goodsell, Josie, Horton, Sarah, Love, Sally, Masters, Benjamin, Rees, Andrew, Sharpe, Simon, Taylor, Kate, Wignall, Suzy, Harrow, Sister Kath, Jones, Lesley, Kanyi, Karen, Keng-Koh, Pek, McGarry, Karen, Ramachandra, Prakash, Watts, Angela, Baumber, Shelley, Howard, Joanna, Jones-Skipper, Kay, Manetta, Caroline, McCrisken, Lauren, Taylor, Jo-Anne, Williams, Amanda, Clark, Alison, Clarke, Maria, Egan, Lisa, Fiddes, Kathleen, Forman, Susan, Gardiner, Fiona, Jeffrey, David, Mariappan, Param, Mayne, Barbara, McLaren, Duncan, Rogers, Brian, Woods, Catherine, Young, Douglas, Anderson, John, Baines, Kizzy, Crundwell, M, Davey, Elizabeth, Lawless, Theresa, Matkins, Ellen, McGinley, Shannon, McGrath, John, Piper, Jane, Roantree, Alison, Seath, Ingrid, Srinivasan, Rajaguru, Stott, Mark, Timmings, Katie, Webb, Claire, Al-hasso, Abdulla, Barwell, Lorraine, Dodds, David, Finnegan, Niall, Griffen, Ailsa, Jones, Rob, Lawless, Claire, MacMillan, Antonia, Russell, Martin, Sadozye, Azmat, Shirley, Sian, Sidek, Norma, Wallace, Jan, Akhtar, Naeem, Bell, Karen, Humpreys, Louise, McWilliam, Donna, Moody, Emma, O'Neil, Rebecca, Peck, Suzannah, Auladin, Raidah, Bird, Stephanie, Bissa, Caterina, Dabbs, Marianne, Di Maria, Fabio, Goh, Chee, Harding, Joshua, Jamieson, Ceri, Jones, Jules, Khaksar, Sara, Laing, Robert, Matthews, Laura, Medisetti, Aruna, Molony-Oates, Barbara, Money-Kyrle, Julian, Nobes, Jenny, Rabsztyn, Weronika, Sidi, Frances, Smale, Daisy May, Stone, Sarah, Tindall, Annie, Woods, Jane, Wu, Min, Daniel, Amelia, Holmes, Evelyn, Kellaway, Joanne, Lewis, Amanda, Light, Teresa, Melcher, Lucinda, Robinson, Lily, Staines, Nikki, Carini, Serrafina, Cooper, Sophie, Evans, Melanie, Follows, Josh, Grant, Warren, Hedges, Andy, Hughes, Claire, Jones (Birch), Janine, King, Lisa, Lees, Laura, Mercer, Lily, Myles, Sophie, Roberts, Zara, Williamson, Nicola, Abbassi, Sara, Alonzi, Roberto, Anyamene, Nicola, Bici, Julia, Collins, Lucy, Dickson, Jeanette, Garrido-Perez, Sandra, Hoskin, Peter, Hughes, Robert, Jenkins, Suzanne, Kowalewska, Paulina, Milner, Jessica, Mitchell, Lesley, Ostler, Peter, Rashid, Aamna, Stapleton, Stephanie, Bashir, Faheem, Bone, Linzi, Clark, Diane, Dixit, Sanjay, Horne, Rhian, Jones, Dawn, Palmer, Sarah, Plowman, Kristian, Rawlings, Julie, Simms, Matthew, Addison, Anglise, Arnott, Seonaid, Borgaonkar, Sudhir, Brown, Sandra, Campbell, Audrey, Colligan, Steve, Cormack, Margaret, Doughty, Victoria, Kelly, Kay, Lister, Debbie, Macdonald, Alison, Macgregor, Carol, Mackay, Rachel, Madeleine, Jude, McNally, Morag, McPhail, Neil, Neville, Sean, Nicholls, Alison, Papakostidi, Aristoula, Simpson, Georgina, Sinclair, Glenda, Skene, Anna, Telfer, Sheena, Urquhart, Zoe, Whillis, David, Etheridge, Charlotte, Ford, Amanda, Ridley, Paul, Scrase, Christopher, Upson, Susan, Venkitaraman, Ramachandran, Capaldi, Lisa, Churn, Mark, Higgins, Linda, Knott, Helen, Stringer (pr. Davis), Sally, Taylor, Jacob, Tranter, Helen, Wollaston, Julie, Brogan (nee Roddie), Stephanie, Erskine, Susan, Hamill, Maureen, Prentice, Lynn, Symon, Lesley, Teahan, Seamus, Todd, Anne, Tweedle, James, Young, Sally, Austin (nee Glover), Gemma, Boon, Ian, Bottomley, David, Breckin, Edmund, Clarke, Jude, Coyle, Catherine, Davies, Emily, Goulding, James, Kiltie, Anne, Loughrey, Carmel, Murad, Fatima, Pratt, Claire, Shuttleworth, Pam, Smith, Beccy, Smith, Gill, Branson (née Dineen), Amy, Christmas, Sallyanne, Cooke, Jill, Griffiths, Leyshon, Kent, Christopher, King, Amy, Kockelbergh, Roger, Potterton, Janet, Speed, Lesley, Vasanthan, Subramanian, Walker, Julia, Baria, Karin, Bateman, Samantha, Coombs, Sarah, Cunningham, Amy, Dahar, Nazeer, Daruwala, Pallon, Francis, Olesya, Hall, Jane, Hoare, Kathryn, Key, Claire, Lockwood, Carol, Mark, Ian, Newton, Rachel, Sloan, Andrew, Bermingham, Nicola, Dean, Lynsey, Malik, Zafar, Pilkington, Pauline, Robson, Peter, Rogers, Heather, Rogers, Thomas, Treherne, Katy, Bourke, Amie, Chikkamuniyappa, Bindu, Dalton-Short, Ross, Edwards, Steve, Falconer, Alison, Ford, Amy, Harinarayanan, Sathish, Hassan, Nebah, Hornzee, Gillian, Magwaro, Sophia, McInerney, Sue, Pratap, Bhavesh, Rezkallah, Sarah, Sadare (Olaleye), Ibiyemi, Stancliffe, May, Stewart, Simon, Thoi, Anne-Maree, Westrop, Anna, Ahamadali, Sheefa, Arsanious, Nasr, Balogun, Shaki, Batish, Cheryl, Campbell, Yvonne, Crowley, Claire, Dunne, Emma, Ferreira, Miguel, Haldeos, Anne, Hijab, Adham, Huddart, Robert, John, Babbin, Michaelidou, Andriana, Nawrozzadeh, Mohammed, Pach, Jackie, Patel, Priyanka, Payne, Ann, Perry, Matthew, Serra, Maria, Springall, Christine, Thompson, Jane, Thomson, Sister Jane, Tree, Alison, Aya, Viviana, Beaney, Ronald, Bower, Lorna, Conway, Lisa-Jane, Donaghey, Sally, Gordon, Hussain, Grau, Isabel, Harris, Sarah, Hogan, Vesna, Hore, Brendan, Hughes, Simon, Jones, Katie, Kuenzig, Greg, Morris, Stephen, Nunney, Dawn, Rashid, Jessica, Reynolds, Philip, Rooprai, Bali, Mangar, Stephen, Azirar, Hanna, Caumont, Tom, Gupta, Nishi, Hill, Judy, Karp, Stephen, Kullane, Sagal, Macavoy, Tina, Neave, Farhad, Newby, Jackie, Van Someren, Chloe, Anderson, Naomi, Annan, Lynda, Cooke, Juniebel, Douch, Emma, Fawcitt, Sara, Gore, Alexandra, Grieve, Sylvia, Jarvis, Claire, McCadden, Angela, Needleman, Sarah, Pigott, Katherine, Powell, Hannah, Ramtohul, Kaliyanee, Rosenfelder, Nicola, Vilarino-Varela, Maria, Ali, Jennyfa, Ali, Maryam, Banda, Laillah-Crystal, Bott, Trevor, Brown, Emmanuel, Bryant, Hanna, Carlino, Giulia, Grant, Cordelia, Hogan, Holly, Khoo, Vincent, Mojidra, Chintan, Montebello, Joseph, Morrison, Jennifer, Olabanji, Matthew, Pillai, Sijy, Siu, Bernard, Stafferton, Ruth, Storrs, Sarah, Townsend-Thorn, Debra, Van As, Nicholas, Vijayakumar, Vijitha, Welsh, Liam, Dearnaley, David, Gao, Annie, Horwich, Alan, Lewington, Val, Marshall, John, Murphy, Louise, Parker, Chris, Beaton, Kirsty, Bech-Nielsen, Nanette, Bolton, Olivia, Conibear, John, Dekaj, Fatjon, Hillman, Paul, Jayachandran, Resmi, Kaliski, Alexandre, Kiff, Janet, Nicholson, Alastair, Nixon, Jude, Oladimeji, Janet, Riches, Oscar, Smith, Dan, Tipples, Karen, Wells, Paula, Anderson, Chris, Daly, Deirdre, Dover, Serena, Gilmartin, Claire, Golden, Sophie, Gregg, Jane, Issa, Rami, Oni, Titilayo, Patel, Chandni, Quarrell, Mark, Rolfe, Debbie, Tighe, Helen, Toledo, Jesusa, Tuazon, Juel, Varro, Robert, Bohra, Vikram, Caballes, Mark, Custins, Laura, Ivie, Stephanie, Joshi, Manisha, Liau, Joy, Naim, Farhan, Patel, Anup, Pathmanathan, Byiravey, Russell, Emily, Tippins, Anna, Agdiran, Didem, Aggarwal, Ajay, Amoaten, Thomas, Aslam, Natasha, Bonsu, Nicole, Butt, Zainab, Danaswamy, Patricia, Davda, Reena, Gillesen, Annelies, Goel, Roshni, Khong, Rachel, Lowi, Suzy, Merrick, Richard, Mitra, Anita, Payne, Heather, Teh, Jonathan, Whinn, Samantha, Woolf, David, Zilkha, Helene, Dawson-Athey, Linda, Foster, Emma, Gillian, Andrew, Green, James, Hines, John, Holden, Simon, Kazingizi, Memory, O'Neill, John, Olaoni, Thompson, Peters, John, Philp, Timothy, Zaidi, Sadaf, Adeyoju, Adebanji, Adinkra, Victoria, Brough, Richard, Brown, Stephen CW, Collins, Gerald, Hardstaff, Lisa, Hill, Pippa, Kujawa, Magda, McCurrie, Marilyn, Townley, Barbara, Woodhouse, Iain, Zafar, Waheed, Beesley, Sharon, Breen, Vivienne, Burrage, Su, Calvert, Clare, Davison, Alison, Dias, Heather, Fossey, Gavin, Hotine, Jodie, Jones, Ifan, Jope, Carmel, Lines, Yvonne, Martins, Sarah, Mercier, Barbara, Murray, Jane, Neshiri, Innocent, Pamphlett, Ian, Phillips, Ann, Rai, Pavnish, Roberts, Verity, Taylor, Henry, Tribe, Lisa, Bottomley, Ian, Buchan, Jonathan, Carpio, Viviana, Choudhury, Ananya, Conroy, Ruth, Cowan, Richard, Davison, Sue, Duncan, Ian, Elliott, Tony, Fair, Kim, Fallaize, Adrian, Flanagan, Laura, Green, Sarah, Harris, Catherine, Hart, Amber, Jones, Cathryn, Livsey, Jacqueline, McCaul, Damian, Nazari, Roonak, Newbery, Carol, O'Connor, Kate, O'Dwyer, Sister Jackie, Oliver, Joanne, Onoge, Ekugbe, Petsa, Maria, Redshaw, Catherine, Smith, Sarah-Ellen, Spoor, Willemijn, Thomas, Sister Viv, White, Holly, Worsley, Lucy, Bailey, Linda, Bennett, Molly, Corless, Rebecca, Duffy, Annie, Fellows, Kathryn, Gipson, Anna, Haydock, Helen, Knox, WF, Liptrott, Sarah, McCarth, Fiona, McCartin, Fiona, Mistry, Heena, Mthethwa, Thobekile, Partington, Lillian, Piper, Lindsay, Ramani, Vijay, Sahin, Sarah, Sangar, Vijay, Slevin, Kathryn, Tuck, Jonathan, Atkinson, Lorraine, Barnbrooke, Sarah, Barnes, Alison, Brownless, Caroline, Chadwick, David, Hardman, John, Harland, Keith, Long, Carol, McAuliffe, Sarah, McBride, Julia, McClurey, Sister Patricia, Mohan, Rita, Naylor, Lynne, Peedell, Clive, Robson, Paula, Shakespeare, Devadasan, Thompson, Emma, Van der Voet, Hans, Wilson, David, Barron, Chris, Frew, John, Lambert, Katy, McMenemin, Rhona, Pedley, Ian, Riseborough, Danielle, Roberts, Trevor, Stockley, Emma, Stoddart, Jonathan, Tate, Janine, Walker, Jayashree, Workman, Bridget, Barnett, Debra, Carter, Adam, Cox, Adam, Davey, Alison, Davies, Kirstin, Gilby, Lisa, Hodge, Simon, Kearney, S, Lavender, Helene, Marty, Janet, Nash, Maxine, Rahman, Syhed, Richards, Jayne, Simpson, Julie, Wall, Elaine, Webb, Paula, Wild, Karen, Wilson, Jim, Branagan, Jenny, Dell, Gillian, Foo, Maxine, Goyena, Ruby, Jones, Andrea, McBain, Hazel, McGrath, Katherine, O'Callaghan, Jane, Ramanathan, Dorai, Tee, Elizabeth, Thominson, Bronwen, Tighe (nee Bussey), Rachel, Beety, Jane, Birch, Richard, Bloomfield, Mark, Callam, Sara, Cooper, Adele, Darby, Helen, Healey, Gail, Heasley, Karen, Kapur, Guarav, London, Clare, Oosterom, Katrien, Ostrowski, Joe, Shobrook, Bridget, Turner, Sarah, Wade, Rob, Walker, Suzanne, Walton, Sharon, Websdale, Cheryl, White, Joanna, Alder, Leanne, Chivers, Rachael, Gooch, Carol, Howard, Lucy, Hutchinson, Camille, Jevons, Cody, Kumar, Daniel, Marley, Hazel, Mills, Jamie, Purves, Hanna, Sayers, Ian, Sundar, Santhanam, Szolin-Jones, Jacob, Walker, Georgina, Wood, Catherine, Cook, Wendy, Gill, Lisa, Johnson, Joanne, Johnstone, Dawn, Jones, Richard, Mistry, Leena, Scarratt, Lyndsay, Aiku, Abimbola, Ajzensztejn, Daniel, Al-Chamali, Hiba, Andrade, Gerard, Barber, Dave, Bekulart, Sylwia, Bhatnagar, Gagan, Boutflower, Jane, Brewster, Simon, Butterfield, Anne, Carroll, Weronika, Cole, David J, Coutts, Tim, Doyle, Kerrie, Durrant, Lisa, Green, Trish, Jampana, Raj, Jastrzebska, Patrycja, Kyffin, Phillippa, Langridge, Nicole, Lawrey, Sarah, Markus, Sarah, Marston, Kerrie, Mooney, Matthew, Mukkath, Sandra, Murphy, Ann, Owens, Rob, Ruane, Sarah, Sabbagh, Ahmad, Samkange, Grace, Sankighatta, Naveen, Skwarski, Michael, Stuart, Robert, Wellman, Sandie, Wilson, Jo, Cavanagh, Kerrie, Hollingdale, Abigail, Allen, Susan, Barter, Elisa, Gregory, Debbie, Ingle, Charlotte, Lawrence, Steph, Rooney, Paula-Joanne, Bishop, Emma, Brennan, Maria, Cogley, Lyn, Hammonds, John Christopher, McInerney, Paul, McLarty, Esther, Natale, Salvatore, Pascoe, Sarah, Purcell, Keith, Sells, Henry, Tyner, Sharah, yates, Victoria, Beamish, Neal, Blaney, Hilary, Clapp, Felicity, Clarke, Elizabeth, Coffin, Teresa, Davies, Joe, Downs, Nichola, Gillespie, Sally, Heckford, Louise, Iskender, Amanda, Orford, Sara, Pressdee, Sandy, Rix, Sophie, Wheelwright, Roger, Woodward, Elizabeth, Wright, Seonaid, Blight, Kathy, Dobson, Tracey, Hale, Jennifer, Harris-Burland, Angie, Khoury, Ghassan, Madhava, Kudingila, Meadows, Lorna, Nagar, Yoodhvir, Roca, Mila, Stacey, Wendy, Stephenson, Anna, Uherek, Maja, Virgo, Azarel, Watkinson, Catrin, Birtle, Alison, Chauhan, Zainab, Cornthwaite, Stephanie, Curtis, Sandra, Ellard, Rose, Fish, Nathan, Hefferon, Billy, Searle, Claire, Spickett, Helen, Walmsley, Catherine, Atkinson, Jane, Brown, Richard B, Cartwright, Debbie, Coomber, Kristy, Hunt, Allison, Kowalczyk-Williams, Wioletta, Lewis, Christina, Parr, Stephen, Purdon, Helen, Rogers, Paul, Vowell, Emma, Featherstone, Wendy, Hamilton, Joanna, Harrison, Alison, Hindle, Margaret, Hodson, Hayley, Isaew, Andrea, Knapp, Jeanette, Moss, Sarah, Gibbs, Stephanie, Gujral, Sandeep, Jannapureddy, Revanth, Kelkar, Anand, Martinou, Maria, Mills-Baldock, Tina, O'Brien, Neale, Subramaniam, Ramachandran, Tahir, Saad, Vandal, Mohammad Tanvir, Vu, Thi, Allen, Rachael, Betts, Chris, Bowmer, Amanda, Clarke, Noel, Cordwell, Amanda, Dharmaprasad, Soney, Duncan (nee Keatley), Claire, Farnworth, Christine, Farrell, Helen, George, Siny, Goulden, Kay, Harter, Leah, Kaushal, Malan, Kirk, Sister Sarah, Lau, Maurice, Lydon, Anne Marie, O'Flynn, Kieran, Platt, Danielle, Shackley, David, Stevenson, Garry, Taylor, Sister Melanie, Thompson, Chloe-Anne, Vinod, Cellins, Wadsworth, Oliver, Youd, Sister Jill, Attlee, Julie, Bhatnagar, Adityanarayan, Bunn, Sarah, Campbell, Allister, El-Saghir, Mohammed, Fennelly, Ruth, Guy, Peter, Mattocks, Lehentha, Mcintosh, Gregor, Murphy, Brenda, Reed, Catherine, Strong-Sheldrake, Sophia, Tedd, Gemma, Dent, Kathleen, Hood, Marion, Martin, Karen, Pearson, Sandra, Potoczna, Dorota, Spencer, Sue, Towse, Jo, Whotton, Nikita, Bowen, Katie, Clark, Su, Clarke, Rachael, Gibbins, Kate, Martin, Jackie, Smith, Suzanne, Spalton, Catherine, Tay, Jessica, Adams, Marion, Bates, Emma, Chennattukungu, Indukala, Clancy, Joanna, Cross, Vanessa, Hughes, Hayley, Jose, Sanal, Kurian-Downer, Sunita, Michael, Elena, Moore, Sister Helen, Nicholas, Karen, Pope, Suzanne, Potts, Sally, Prashant, Ravi, Singh, Harpreet, Smith, Sandra, Srihari, Narayanan, Weaver, Emma, Abbas, Ali, Barnes, Nicky, Dallas, Nicola, Jackson, Sister Ann, Kader, Nicole, Karim, Omer, Laniado, M, Litchfield, Jayne, Mahmood, Sana, O'Donnell, Helen, Robinson, Victoria, Sears, Alison, Sharif, Shahid, Sierra Pala, Ana, Sinclair, Julie-Ann, Smith, Sister Catherine, Ashcroft, Jan, Boardman, John, Bowes-Cavanagh, Jeanette, Brown, Rebecca, Chedham, Alison, Darch, Flora, Farrar, Michelle, Foot, Jayne, Goldsworthy, Simon, Graham, John, Gray, Emma, Green, Sara, Jelski, Joseph, Kalejaiye, Odunayo, Keni, Manjusha, Locke, Angela, Mahoney, Sue, McMeekin, Faith, Periasamy, Manivannan, Russell, Tamlyn, Ruszala, Elizabeth, Segaran, Surayne, Tighe, Mary, Wallbutton, Rebecca, Webster, Christine, Whitcher, Alison, Wiggins, Sarah, Wrigley, Martha, Zietz, Maria, Abab, Julie, Cumming, Kirsty, Galloway, Lucy, Ganabady, Malavika, Haskell, Annelise, Heath, Catherine, James, Naomi, Kennedy, Julie, McFarlane, Victoria, Morales-Azofra, Fabiola, Morton, Susan, Mundy, Carina, Noble, Mark, Paschalis, Alec, Patrick, Julie, Reader, Leanne, Taylor, Lisa, Wakefield, Shauna, Ahmed, Imtiaz, Bowman, Sue, Chan, Olivia, Cyriac, Abby, Davies, Tracey, Maitland, Katrina, Prejbisz, Jan, Reece, Sheila, Shires, Heather, Tsang, David, Anscombe, Eleanor, Brough, WA, Clitheroe, Pat, Cocks, Tracie, Connolly nee McKenna, Sarah, Corcoran, Sam, Coughlan, Tricia, Gilmour, Christina, Goodwin, Emma, Graham, Susan, Hatimy, Umi, Hodgkinson, Sheila, Kilmartin, John, Orrell, Lucy, Rotherham, Carol, Smallwood, Sarah, Taylor, Jill, Wiss, Elliott, Adab, Fawzi, Bhana, Rajanee, Dhinakaran, Kathirvelu, Evans, Marion, Myatt, Alison, Parkinson, Katrina, Peake, Angela, Sellars, Elizabeth, Smith, Rowena, Storer, Julie, Thomasson, Georgia, Vengalil, Salil, Walton, Jenny, Ward, Angela, Boam, Samantha, Burgoyne, Jamie-Rae, Chadwick, Eliot, Gill, Shafiq, Haigh, Steve, Hollis, Keri, Lim, Jun, McCabe, Alastair, Munson, Lyndsey, Nash, Dominic, Saunders, Daniel, Smith, Susan, Wade, Lynne, Evans, Elizabeth, Franklin, Alex, Harris (n. Marchant), Emily, Johnstone, Maria, Jones, Lewis, Lemon, Nicola, Phan, Mau-Don, Pudney, Delia, Spence, Rachael, Stretch, Alison, Tait, Ellen, Williams, Bethan, Belcher, Rebecca, De Silva-Minor, Shiroma, Dodge, Sister Jan, Grayland, Sarah, Jones, Ania, Khan, Omar, Owen, Tim, Palmer, Debbie, Parajes, Cerila, Pegler, Suzannah, Poole, Abbie, Sargent, Sister Tracey, Starling, Ellen, Taylor, Becky, Winter, Sister Helen, Zinyemba, Vivian, Allison, Michele, Blundell, Martyn, Brookman, Catherine, Buckley, Jon, Chamberlain, Shelley, Cuffe, Donna, Davies, Stacey, Fairfax, Claire, Greedus, Helen, Griffin, Hannah, Koehler, Ingrid, Lydon, Anna, Michels, Jorg, Pym, Julia, Roberts, Fiona, Thornton, Lorraine, Vandecandalaere, Elaine, Watts, Erica, Welsh, Linda, Anderson, Jim, Anderson, Juliette, Ball, Julie, Benton, Louise, Bowers, Richard, Chahal, Rohit, Dickinson, Peter, Fosker, Chris, Heeley, Janine, Kanaga-Sundaram, Subramanian, Littler, Stephen, Slack, Jonathan, Sundaram, Subramanian Kanaga, Taylor, Beverley, Weston, Philip, Chettle, Judith, Hartwell, Lyn, Johnson-Rollings, Ashley, Jones, Julia, Millage, Helen, O'Neill, Eilish, Walsh, Donna, Webb, Kerrie, Williams, Jo, Dymond, Harvey, Eleftheriadis, Symeon, Lloyd-Jones, Hugh, Wells, Tom, Bennett, Sarah, Dunn, Sharon, Fildes, Diane, Hassall, Alison, Herbert, Gaynor, Hughes, Kathryn, Innes, Helen, Kelly, Alison, Littler, John, Lomax, Laurie, Miller, Nikki, Nutman, Chris, Stott, Matthew, Syndikus, Isabel, Tolan, Shaun, Weston, Alison, Baker, Ivanna, Carter, Vanda, Chatfield, Jenny, Cooke, Peter, Grant, Anna, Homer, David, Kirk, Christine, Lomas, Claire, McCormick, Marian, Mohseeni, Arizoo, Pawaroo, Renita, Radford, Liz, Rogers, Jason, Samanci, Ali, Sharman, Emma, Spencer, Hazel, Spruce, Debbie, Worthington, Hannah, Bak, Dagmara, Cleary, Kristy, Davies, Sue, Gauntlett, Monica, Gupta, Kamalnayan, Holdsworth, Amanda, Ledger, Kate, Morrow, Hugh, Perry, Heather, Rimell, Patricia, Rosoman, Alison, Tyler, Jayne, White, Ann, Crowe (nee Hughes), Dawn, Flynn-Batham, Marian, Folkes, Linda, Funnell, Sarah, Gilbert, Jeanette, Gomez-Marcos, Raquel, Gonzalez, Celia, Hoskins, Chloe, Moore, Sally, Plataniotis, George, Rippin, Sarah, Smith, Matthew, Tsawayo, Tan, Turner, Nikki, Wakelen, Paula, Cserbane, Anita, Fernandez, Claire, Kurup, Rahul, Manyangadze, Sarah, McLain-Smith, Susan, Protheroe, Andrew, Trewsmith, Neil, Allison, Joanna, Barron, Claire, Beaumont, Erica, Beer, Nigel, Beesley, Kate, Donaldson, David, Duckett, Tracey, Fox, Shirley, Kotze, Michelle, Kumar, Shiyam, Macrory, Joanne, Perry, Jess, Pippard, Lucy, Porter, Tim, Rennie, Kerry, Sparrow, Geoffrey, Williams-Yesson, Barbara, Balderson, Jane, Bowling, Lorna, Brittain, Paul, Brookes, Claire, Campbell, Hilary, Campos, Monica, Conway, Rachel, Davies, Flor, Donnison, Michelle, Elliott, Mark, Evans, Richard, Fallah, Fereshteh, Fearnley, Mark, Giddings, Emma, Gollapothu, Srilakshmi, Harvey, Sally, Holbrook, Andy, Ingham, Jo, Jakeman, Christine, Joseph, Joji, Mole, Lisa, Musunuru, Hima Bindu, Pashley, Sarah, Saleem, Shamila, Stower, Michael, Strider, Paula, Taylor, Carol, Thackray, Louis, Todd, Joanna, Wightman, John, Wilson, Russ, Youngs, Nora, Byrne, Mary Marg, Deenihan, Emma, Durkan, Garret, Jennings, Marian, Mahoney, Catriona, Martin, Joseph, McInerney, Veronica, Raftery, Liz, Rogers, Eamonn, Spillane, Maria, Sullivan, Frank, Teh, Chiaw Woon, Wright, Ann, Harving, Niels, Hejlesen, Finn, Kempel, Mette Moe, Steffensen, Kirsten, Bentzen, Lise, Borre, Michael, Buus, Simon, Fode, Kirsten, Kaa Bach, Birgit, Lassen, Yasmin, Laursen, Vibeke, Lemng Kruse, Helle, Lucakova, Slavka, Nørmark Iversen, Helle, Brasso, Klaus, Christensen, Anne Juel, Gruschy, Lisa, Klovgaard, Karina, Lunau, Anne Sofie, Meidhal Petersen, Peter, Moller Christensen, Trine, Poder, Lone Lund, Ribers, Kristine, Stilling, Sine, Thim, Stine, Torin Lehmann, Anna, Vandborg, Maria, Christensen, Tine, Kokholm, Kathrine Friser, Lindberg, Henriette, Nybom, Kirstine, Rønnengart, Eva, Saxe, Charlotte, Baird, Noelle, Braun, Michael W, Cheung, Arthur, Fourt, Monica, Jackson, Cathy, Jepson, Debbie, Johnson, Arlissa, Karvat, Anand, Kwan, Winkle, McIndoe, Sue, Mitchell, Donna, Sandhu, Sandeep, Serpanchy, Rosanne, Wu, Helen, Beausoleil, Rachelle, Crawford, Melanie, DiMarco, Christine, Ding, Ian, Gladwish, Adam, MacIsaac, Patricia, MarshGray, Kimberley, Morton, Gerard, Murphy, Cara, Pascoe, Caitlin, Pokhrel, Sujata, Stevens, Christiaan, Yoon, Frederick, Yu, Jason, Dubey, Arbind, Sivananthan, Gokulan, Bahary, JeanPaul, Barkati, Maroie, Beauchemin, MarieClaude, Benth, Silvine, Carbonaro, Adriana, Delouya, Guila, ElSokhn, Nidale, Frazzi, Alexandra, Lambert, Carole, Lavertu, Sophie, Menard, Cynthia, Pan, Siew Siew, Rousseau, Pierre, Saad, Fred, Taussky, Daniel, Trudel, Diane, Amanie, John Oliver, Batz, Margaret, Borynec, Carol, Danielson, Brita, Garcia, Leni Santiago, Gramlich, Colin, Lang, Monika, Larson, Beverly, Mallett, Debbie, McCrudden, Sylvia, Murtha, Albert, Parker, Shelley, Parliament, Matthew B, Patel, Samir, Pearcey, Robert, Pervez, Nadeem, Rose, Jim, Shewchuk, Caroline, Smith, Carlie, Usmani, Nawaid, Williams, Candra, Yee, Don, AlRashdan, Abdulla, Avery, Alison, Beaton, Heather, Bond, Brittany, BrucePayne, Kim, Burbridge, Susan, Bursey, Kara, Carvery, Lane, Dill, Kendra, Dugas, Stevie, Harding, Claudia, Hodder, June, Hollenhorst, Helmut, Hubley, Lynn, Joseph, Paul K, Little, Erin, MacDonald, Angela, MacIsaac, Kathy, MacVicar, Jennifer, McCracken, Jillian, Moffatt, Emily, Nieforth, Joan, Patil, Nikhilesh, Rijt, Kelsey van der, Roberts, Victoria, Rose, Tina, Rutledge, Robert DH, Salyzyn, Camryn, Simpson, Robin, Sutherland, Donna, Walker, Heather, Wilke, Derek, Yeo, Tanya, Yunace, Lorrie, Zinck, Connie, Bier, Bianca, Bucci, Catherine, Corbett, Thomas B, Dayes, Ian S, Eady, Robin, Gudelis, Susan O, Hill, Elaine, Kinrade, Yvonne, Laughlin, Anne, Lukka, Himu, Makepeace, Barbara, Marshall, Lynn, Nielsen, Linda, Oliverio, Carmela, Patel, Malti Behn, Tsakirdis, Thedoros, Wong, Jason W T, Allen, Kirsten, Bachand, Francois, Carefoot, Layton, Cotts, Shannon, Creelman, Brianna, Crook, Juanita, GeorgeChayka, Danielle, Halperin, Ross, Hartt, Nancy, Hayes, Jill A, Kim, David, Kim, TuongVan, Kronstal, Flo, Lee, Bernard, Lew, Tanya, McClelland, Marie, Opitz, Debbie, Overend, Aldyn, Reed, Melanie, Watson, Michaella, Wilkie, Karen, Winn, Carol, Yanchuk, Janet, Bonner, Scott, Brander, Mike, Brundage, Michael, Carlson, Cindy, Edwards, Jackie, ElKerdawy, Hala, Harpell, Rhonda, Hartman, Carrie, Kalyvas, Maria, KirbyBello, Denise, Kumar, Vikaash, Leach, Deborah, MacVicar, Karen, Mahmud, Aamer, Maize, Christine, Moelker, Yvonne, Murano, Abby, Paul, Nancy, Ross, Ashley, RossSmith, Marleen, Shenfield, Carey, Spencer, Craig, Tennant, Virginia, Vermette, Tracy, Willing, Stephanie, Zaza, Khaled O, Zeltser, Fred, Gearing, Jennifer, Girolametto, Carla, Gopaul, Darindra, Hamilton, Ronald, Hendel, Debra, Janke, Susan, Knackstedt, Jochen, Kuk, Joda, Morrison, MaryBeth, Mumin, Anissa, Nemirov, Stephanie, Rachakonda, Ramana, Shantz, Brenda S, Siddiqui, Atif, Thallury, Sheeba, Ahmad, Belal, Bailey, Laura, Bauman, Glenn, Camara, Mary Jane, Corkery, Danylle, DSouza, David, DiLullo, Elenor, Eichenberger, Lois, Francis, Peggy, Grant, Susan, Gratton, Albert, Gurzanski, Christina, Hare, Jennifer A, Johnson, Craig, Kenny, Shannon, Lock, Michael I, Loughlin, Kate, Mardell, Stephen, Mayer, Heather, Rodrigues, George B, Sax, Lori, Sebborn, Kes, Sexton, Tracy, Venkatesan, Varagur M, tenHaaf, Darlene, Chatelain, AnneMarie, Fortin, Jacqueline, Houle, Stefanie, Khaouam, Nader, Lachance, Nicole, Laliberte, Benoit, Lemaire, Celine, Nguyen, David H A, Sylvestre, Alma, Vavassis, Peter, Yassa, Michael, Adnaan, Jamila, Briand, Wayne, Casey, Linda, Chipman, Penny, Corwin, Charlotte, Duclos, Marie, Faria, Sergio Luiz, Ghoul, Mokhtar, Joncas, MarieClaude, Koulouris, Zoe, Larocque, Stephanie, Lee, Brenda, Olha, Carolynna, Robert, MarieFrance, Sharma, Rajesh, Shenouda, George, Souhami, Luis, Albrecht, Virginia, Froese, Jane, Froude, Nancy, Howitt, Pamela, Iqbal, Fawaad, Kift, Shannon, Koll, Wayne, Li, Audrey, MacGregor, Barbara, Manganaro, Aileen, McKee, Dianne, Mendoza, Edeliza, Mui, Jimmy, Myrehaug, Sten, Singson, Angelina, Slessor, Janet, Somasiri, Ashane, Stevens, Nicole, Berghout, Koralee, Bourque, JeanMarc, Carkner, Amy, E, Choan, Eapen, Libni, Eze, Nancy, Fish, Matt, Haddad, Alain, Hicks, Kimberly, Iordanidi, Elina, Kanji, Femina, Kendal, Wayne S, MacMullin, Lisa, MacRae, Robert M, Malone, Shawn, Morgan, Scott, Nguyen, Julie, OBrien, Anna, Page, Nancy, Perry, Gad A, Reeves, MarieClaude, Roach, Joanne, Sanchez, Maria, Spearman, Mary, Spencer, Patti, Tikoo, Archana, Turriff, Lisa, Wright, Natalie, Bedoya, Luis Diaz de, Cossette, Danielle, Cusan, Leonello, Desrosiers, Isabelle, Dufour, Nathalie, Foster, William, Gomez, JoseLuis, Hathout, Lara, Lajoie, MarieAndree, Martin, AndreGuy, Pouliot, Sophie, Vigneault, Eric, Bouchard, Myriam, Bujold, Rachel, Carmel, Michel, Cote, Genevieve, Dion, Helene, Ebacher, Annie, Gauthier, Isabelle C, Ladouceur, Cynthia, Lamoureux, Alexandra, Larouche, Julie, Marquis, Tania, Nabid, Abdenour, Pearson, Diane, Sabbagh, Robert, TetreaultLaflamme, Audrey, Baker, Erin, Blackwood, Geoffrey, Galway, Denise, Greenland, Jonathan, Hannaford, Zeta, Hoskins, Ashley, House, Gail, Kamran, Asim, Manning, Kimberley, Nelder, Matthew, Noel, Lorilee, Norman, Alia, ODea, Jamie, Pinnell, Erin, Pochini, Craig, Putt, Dawne, Rahman, Arifur, Rickert, Lauren, Sathya, Jinka R, Teasdale, Breanne, Thoms, John, Whiteway, Chrystal, Whittle, Stacy, Cheung, Patrick CF, Chu, William, Chung, Hans T, Commisso, Angela, Danjoux, Cyril, Escueta, Vivette, Klotz, Laurence, Leung, Michael, Liu, Stanley, Loblaw, Douglas Andrew, Malek, Leila, Nam, Robert K, Szumacher, Ewa, Tseng, Eric Chia Lin, Vesprini, Danny, Abed, Jessy, Ang, Daniel, Bayley, Andrew J, Berlin, Alejandro, Bristow, Robert, Catton, Charles, Chan, Heidi, Chui, Amadeus, Chung, Peter, Degendorfer, Sarah, Gospodarowicz, Mary, Gregorcic, Emily, Gumapac, Nicole, Helou, Joelle, Hsien, John, Kong, Vickie, Lalani, Nafisha, Lao, Bernadeth, Lawson, Daeria, Merante, Pat, Milosevic, Michael, Mirmooji, Ramesh, Muraj, Zaynab, Peres, Sarin, Petroff, Avi, Petrovska, Aleksandra, Pineda, Sandra, Quintos, Judy, Raman, Srinivas, Ramotar, Sarah, Ruiz, Maria Jose Gaitan, Sabate, Kathryn, Shukla, Arundhati, Tharahan, Nanthini, Thevarajah, Vaishaali, Tiessen, Kyoko, Topalovich, Aleksandra, Torres, Cynthia, Tse, Karen, Tsuji, Debbie, Velec, Erin, Wallace, Kris, Warde, Padraig, Bisson, MarieEve, Dahmane, Rafika, Gagne, Vanessa, Harvey, Julie, Lebrun, Benoit, Marineau, Line, Montour, Julie, Samson, Julie, Sicard, MarieEve, Thibeault, Andreanne, Vincent, Francois, Vincent, LindaSuzanne, Blood, Paul A, Canavan, Joycelin, Clements, Mia AnnaMaria, Glick, Daniel, Holloway, Caroline, Holwerda, Eleanor, Joe, Howard, Lacey, Cathy, Lam, Jacqueline, Leong, Nelson, Lim, Jan, Lomas, Alia, Pai, Howard H, Priestley, Emilie, Shahid, Negin, Vallieres, Isabelle, Duncan, Graeme, Gleave, Martin E, Goldenberg, S Larry, Karunakaran, Subashini, Keyes, Mira, KimSing, Charmaine, McKenzie, Michael, Morris, William James, Nakashima, Lynne, Peacock, Michael, Pickles, Thomas A, Sibug, Sheena, So, Alan I, Tyldesley, Scott, Zhang, Tina Wanting, Ahmed, Shahida, Ammeter, Barb, Anderson, Leanne, Ann, Taehee, Bakija, Zeljka, Bashir, Bashir, Benjaminson, Patricia, Bergen, Leah, Cadiz, Lovely, Chahine, Jacqueline, Cherepak, Kathy, Chornopyski, Tracy, Chowdhury, Amitava D, Davies, Heather, Dawe, David, Drachenberg, Darrel E, DuMontier, Joelle, Eska, Tiffani, Francisco, Cristina, Gamez, Raquel, Garrett, Gina, Giovannini, Julia, Graham, Jeffrey, Guarino, Robyn, Hunter, William, Johnston, Laurel, Kitkowski, Caitlin, Klapp, Kathi, Koul, Rashmi, Kuzyk, Valerie, Last, Debbie, Li, KuanLin, Long, Heather, Majumdar, Arpita, Marek, Kathleen, McNish, Jennifer, Mills, Laurie, Morales, Maria, Nashed, Maged, Nichol, Rhonda, Ong, Aldrich Dixon, Ouelette, Ashley, Patel, DeepKumar, Pawl, Marilyn, Peak, Lisa, Priebe, Shauna, Quon, Harvey, Rizzuto, Stacey, Rudnicki, Rayleen, Santos, Priscilla, Sharma, Atul, Squires, Mandy, Trakalo, Kathy, Turner, Christy, Vaughn, Jamie, Walker, Lori, Watson, Melanie R, Wei, Joyce, Weir, JoAnn, Woloshyn, Rose, Wood, Allison, Zhang, Hanbo, Zwarych, Darlene, Parker, Chris C, Clarke, Noel W, Cook, Adrian D, Catton, Charles N, Cross, William R, Petersen, Peter M, Persad, Rajendra A, Bower, Lorna C, Bottomley, David M, Branagan, Jennifer, Chung, Peter W M, Goh, Chee L, Malone, Shawn C, Morris, Stephen L, Ong, Aldrich D, Tarver, Kathryn L, Tree, Alison C, Wylie, James P, Zarkar, Anjali M, Parulekar, Wendy R, Parmar, Mahesh K B, and Sydes, Matthew R
- Published
- 2024
- Full Text
- View/download PDF
9. Evaluating the Outcomes of Active Surveillance in Grade Group 2 Prostate Cancer: Prospective Results from the Canary PASS Cohort
- Author
-
Malaret, Adrian J Waisman, Chang, Peter, Zhu, Kehao, Zheng, Yingye, Newcomb, Lisa F, Liu, Menghan, McKenney, Jesse K, Brooks, James D, Carroll, Peter, Dash, Atreya, Filson, Christopher P, Gleave, Martin E, Liss, Michael, Martin, Frances M, Morgan, Todd M, Nelson, Peter S, Lin, Daniel W, and Wagner, Andrew A
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Oncology and Carcinogenesis ,Clinical Trials and Supportive Activities ,Clinical Research ,Cancer ,Urologic Diseases ,Prostate Cancer ,Patient Safety ,Aging ,Prevention ,Detection ,screening and diagnosis ,4.2 Evaluation of markers and technologies ,Aged ,Biopsy ,Canada ,Humans ,Male ,Middle Aged ,Neoplasm Grading ,Neoplasm Recurrence ,Local ,Proportional Hazards Models ,Prospective Studies ,Prostatectomy ,Prostatic Neoplasms ,Regression Analysis ,Risk Assessment ,Time-to-Treatment ,United States ,Watchful Waiting ,prostatic neoplasms ,watchful waiting ,neoplasm grading ,Urology & Nephrology ,Clinical sciences - Abstract
PurposeActive surveillance (AS) for grade group (GG) 2 patients is not yet well defined. We sought to compare clinical outcomes of men with GG1 and GG2 prostate cancer undergoing AS in a large prospective North American cohort.Materials and methodsParticipants were prospectively enrolled in an AS study with protocol-directed followup at 10 centers in the U.S. and Canada. We evaluated time from diagnosis to biopsy grade reclassification and time to treatment. In men treated after initial surveillance, adverse pathology and recurrence were also analyzed.ResultsAt diagnosis, 154 (9%) had GG2 and 1,574 (91%) had GG1. Five-year reclassification rates were similar between GG2 and GG1 (30% vs 37%, p=0.11). However, more patients with GG2 were treated at 5 years (58% vs 34%, p
- Published
- 2022
10. Prostate Cancer Risk Stratification by Digital Histopathology and Deep Learning
- Author
-
Shao, Yanan, Bazargani, Roozbeh, Karimi, Davood, Wang, Jane, Fazli, Ladan, Goldenberg, S. Larry, Gleave, Martin E., Black, Peter C., Bashashati, Ali, and Salcudean, Septimiu
- Published
- 2024
- Full Text
- View/download PDF
11. Treatment in the absence of disease reclassification among men on active surveillance for prostate cancer
- Author
-
Kirk, Peter S, Zhu, Kehao, Zheng, Yingye, Newcomb, Lisa F, Schenk, Jeannette M, Brooks, James D, Carroll, Peter R, Dash, Atreya, Ellis, William J, Filson, Christopher P, Gleave, Martin E, Liss, Michael, Martin, Frances, McKenney, Jesse K, Morgan, Todd M, Nelson, Peter S, Thompson, Ian M, Wagner, Andrew A, Lin, Daniel W, and Gore, John L
- Subjects
Cancer ,Urologic Diseases ,Prostate Cancer ,Aging ,Clinical Research ,Prevention ,Humans ,Male ,Neoplasm Grading ,Prospective Studies ,Prostate-Specific Antigen ,Prostatic Neoplasms ,Quality of Life ,Watchful Waiting ,active surveillance ,prostatic neoplasms ,quality of life ,Oncology and Carcinogenesis ,Public Health and Health Services ,Oncology & Carcinogenesis - Abstract
BackgroundMaintaining men on active surveillance for prostate cancer can be challenging. Although most men who eventually undergo treatment have experienced clinical progression, a smaller subset elects treatment in the absence of disease reclassification. This study sought to understand factors associated with treatment in a large, contemporary, prospective cohort.MethodsThis study identified 1789 men in the Canary Prostate Cancer Active Surveillance Study cohort enrolled as of 2020 with a median follow-up of 5.6 years. Clinical and demographic data as well as information on patient-reported quality of life and urinary symptoms were used in multivariable Cox proportional hazards regression models to identify factors associated with the time to treatment RESULTS: Within 4 years of their diagnosis, 33% of men (95% confidence interval [CI], 30%-35%) underwent treatment, and 10% (95% CI, 9%-12%) were treated in the absence of reclassification. The most significant factor associated with any treatment was an increasing Gleason grade group (adjusted hazard ratio [aHR], 14.5; 95% CI, 11.7-17.9). Urinary quality-of-life scores were associated with treatment without reclassification (aHR comparing "mostly dissatisfied/terrible" with "pleased/mixed," 2.65; 95% CI, 1.54-4.59). In a subset analysis (n = 692), married men, compared with single men, were more likely to undergo treatment in the absence of reclassification (aHR, 2.63; 95% CI, 1.04-6.66).ConclusionsA substantial number of men with prostate cancer undergo treatment in the absence of clinical changes in their cancers, and quality-of-life changes and marital status may be important factors in these decisions.Lay summaryThis analysis of men on active surveillance for prostate cancer shows that approximately 1 in 10 men will decide to be treated within 4 years of their diagnosis even if their cancer is stable. These choices may be related in part to quality-or-life or spousal concerns.
- Published
- 2022
12. On regioselective monoacylation of abamectin and ivermectin aglycones
- Author
-
Vashchenko, Iryna, Veselovska, Mariya, Dolgonos, Grygoriy A., Lukin, Oleg, Poyarkov, Alexey, Kiyenko, Tetyana, Gleave, Martin E., Fetyukhin, Volodymyr, Shivanyuk, Alexander, Gentile, Francesco, and Cherkasov, Artem
- Published
- 2023
- Full Text
- View/download PDF
13. Magnetic Resonance Imaging for the Detection of High Grade Cancer in the Canary Prostate Active Surveillance Study.
- Author
-
Liss, Michael A, Newcomb, Lisa F, Zheng, Yingye, Garcia, Michael P, Filson, Christopher P, Boyer, Hilary, Brooks, James D, Carroll, Peter R, Cooperberg, Matthew R, Ellis, William J, Gleave, Martin E, Martin, Frances M, Morgan, Todd, Nelson, Peter S, Wagner, Andrew A, Thompson, Ian M, and Lin, Daniel W
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Oncology and Carcinogenesis ,Prostate Cancer ,Clinical Research ,Cancer ,Urologic Diseases ,Prevention ,Aging ,4.2 Evaluation of markers and technologies ,4.1 Discovery and preclinical testing of markers and technologies ,Detection ,screening and diagnosis ,Aged ,Humans ,Magnetic Resonance Imaging ,Male ,Middle Aged ,Neoplasm Grading ,Prospective Studies ,Prostatic Neoplasms ,Watchful Waiting ,prostatic neoplasms ,magnetic resonance imaging ,Urology & Nephrology ,Clinical sciences - Abstract
PurposeWe investigated the ability of prostate magnetic resonance imaging to detect Gleason Grade Group 2 or greater cancer in a standardized, multi-institutional active surveillance cohort.Materials and methodsWe evaluated men enrolled in Canary Prostate Active Surveillance Study with Gleason Grade Group less than 2 and who underwent biopsy within 12 months of multiparametric magnetic resonance imaging. Our primary outcome was biopsy reclassification to Gleason Grade Group 2 or greater. We evaluated the performance of magnetic resonance imaging PI-RADS® score and clinical factors. Multivariable logistic regression models were fit with magnetic resonance imaging and clinical factors and used to perform receiver operating curve analyses.ResultsThere were 361 participants with 395 prostate magnetic resonance imaging studies with a median followup of 4.1 (IQR 2.0-7.6) years. Overall 108 (27%) biopsies showed reclassification. Defining positive magnetic resonance imaging as PI-RADS 3-5, the negative predictive value and positive predictive value for detecting Gleason Grade Group 2 or greater cancer was 83% (95% CI 76-90) and 31% (95% CI 26-37), respectively. PI-RADS was significantly associated with reclassification (PI-RADS 5 vs 1 and 2 OR 2.71, 95% CI 1.21-6.17, p=0.016) in a multivariable model but did not improve upon a model with only clinical factors (AUC 0.768 vs 0.762). In 194 fusion biopsies higher grade cancer was found in targeted cores in 21 (11%) instances, while 25 (13%) had higher grade cancer in the systematic cores.ConclusionsThis study adds the largest cohort data to the body of literature for magnetic resonance imaging in active surveillance, recommending systematic biopsy in patients with negative magnetic resonance imaging and the inclusion of systematic biopsy in patients with positive magnetic resonance imaging.
- Published
- 2020
14. African American Race is Not Associated with Risk of Reclassification during Active Surveillance: Results from the Canary Prostate Cancer Active Surveillance Study.
- Author
-
Schenk, Jeannette M, Newcomb, Lisa F, Zheng, Yingye, Faino, Anna V, Zhu, Kehao, Nyame, Yaw A, Brooks, James D, Carroll, Peter R, Cooperberg, Matthew R, Dash, Atreya, Filson, Christopher P, Gleave, Martin E, Liss, Michael, Martin, Francis M, Morgan, Todd M, Nelson, Peter S, Thompson, Ian M, Wagner, Andrew A, and Lin, Daniel W
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Oncology and Carcinogenesis ,Aging ,Prevention ,Patient Safety ,Clinical Research ,Prostate Cancer ,Urologic Diseases ,Cancer ,Good Health and Well Being ,Black or African American ,Aged ,Biopsy ,Large-Core Needle ,Humans ,Kallikreins ,Male ,Middle Aged ,Neoplasm Grading ,Practice Guidelines as Topic ,Prospective Studies ,Prostate ,Prostate-Specific Antigen ,Prostatectomy ,Prostatic Neoplasms ,United States ,Watchful Waiting ,White People ,prostatic neoplasms ,risk ,African Americans ,watchful waiting ,prostatectomy ,Urology & Nephrology ,Clinical sciences - Abstract
PurposeIn a large, prospective, multi-institutional active surveillance cohort we evaluated whether African American men are at higher risk for reclassification.Materials and methodsThe Canary PASS (Prostate Active Surveillance Study) is a protocol driven, active surveillance cohort with a prespecified prostate specific antigen and surveillance biopsy regimen. Men included in this study had Gleason Grade Group 1 or 2 disease at diagnosis and fewer than 5 years between diagnosis and enrollment, and had undergone 1 or more surveillance biopsies. The reclassification risk, defined as an increase in the Gleason score on subsequent biopsy, was compared between African American and Caucasian American men using Cox proportional hazards models. In the subset of men who underwent delayed prostatectomy the rate of adverse pathology findings, defined as pT3a or greater disease, or Gleason Grade Group 3 or greater, was compared in African American and Caucasian American men.ResultsOf the 1,315 men 89 (7%) were African American and 1,226 (93%) were Caucasian American. There was no difference in the treatment rate in African American and Caucasian American men. In multivariate models African American race was not associated with the risk of reclassification (HR 1.16, 95% CI 0.78-1.72). Of the 441 men who underwent prostatectomy after a period of active surveillance the rate of adverse pathology was similar in those who were African American and Caucasian American (46% vs 47%, p=0.99).ConclusionsOf men on active surveillance who followed a standardized protocol of regular prostate specific antigen testing and biopsy those who were African American were not at increased risk for pathological reclassification while on active surveillance, or for adverse pathology findings at prostatectomy. Active surveillance appears to be an appropriate management strategy for African American men with favorable risk prostate cancer.
- Published
- 2020
15. Deep whole-genome ctDNA chronology of treatment-resistant prostate cancer
- Author
-
Herberts, Cameron, Annala, Matti, Sipola, Joonatan, Ng, Sarah W. S., Chen, Xinyi E., Nurminen, Anssi, Korhonen, Olga V., Munzur, Aslı D., Beja, Kevin, Schönlau, Elena, Bernales, Cecily Q., Ritch, Elie, Bacon, Jack V. W., Lack, Nathan A., Nykter, Matti, Aggarwal, Rahul, Small, Eric J., Gleave, Martin E., Quigley, David A., Feng, Felix Y., Chi, Kim N., and Wyatt, Alexander W.
- Published
- 2022
- Full Text
- View/download PDF
16. MEK-ERK signaling is a therapeutic target in metastatic castration resistant prostate cancer
- Author
-
Nickols, Nicholas G, Nazarian, Ramin, Zhao, Shuang G, Tan, Victor, Uzunangelov, Vladislav, Xia, Zheng, Baertsch, Robert, Neeman, Elad, Gao, Allen C, Thomas, George V, Howard, Lauren, De Hoedt, Amanda M, Stuart, Josh, Goldstein, Theodore, Chi, Kim, Gleave, Martin E, Graff, Julie N, Beer, Tomasz M, Drake, Justin M, Evans, Christopher P, Aggarwal, Rahul, Foye, Adam, Feng, Felix Y, Small, Eric J, Aronson, William J, Freedland, Stephen J, Witte, Owen N, Huang, Jiaoti, Alumkal, Joshi J, Reiter, Robert E, and Rettig, Matthew B
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Oncology and Carcinogenesis ,Prostate Cancer ,Biotechnology ,Urologic Diseases ,Clinical Research ,Clinical Trials and Supportive Activities ,Cancer ,Genetics ,6.1 Pharmaceuticals ,5.1 Pharmaceuticals ,Aged ,Antineoplastic Agents ,Biopsy ,Disease-Free Survival ,Gene Amplification ,Gene Expression Regulation ,Neoplastic ,Humans ,MAP Kinase Signaling System ,Male ,Middle Aged ,Mitogen-Activated Protein Kinase 3 ,Molecular Targeted Therapy ,Phosphorylation ,Prospective Studies ,Prostate ,Prostatic Neoplasms ,Castration-Resistant ,Protein Kinase Inhibitors ,Pyridones ,Pyrimidinones ,RNA-Seq ,Urology & Nephrology ,Clinical sciences ,Oncology and carcinogenesis - Abstract
BackgroundMetastatic castration resistant prostate cancer (mCRPC) is incurable and progression after drugs that target the androgen receptor-signaling axis is inevitable. Thus, there is an urgent need to develop more effective treatments beyond hormonal manipulation. We sought to identify activated kinases in mCRPC as therapeutic targets for existing, approved agents, with the goal of identifying candidate drugs for rapid translation into proof of concept Phase II trials in mCRPC.MethodsTo identify evidence of activation of druggable kinases in these patients, we compared mRNA expression from metastatic biopsies of patients with mCRPC (n = 101) to mRNA expression in localized prostate from TCGA and used this analysis to infer differential kinase activity. In addition, we assessed the differential phosphorylation levels for key MAPK pathway kinases between mCRPC and localized prostate cancers.ResultsTranscriptomic profiling of 101 patients with mCRPC as compared to patients with localized prostate cancer identified evidence of hyperactive ERK1, and whole genome sequencing revealed frequent amplifications of members of the MAPK pathway in 32% of this cohort. Next, we confirmed elevated levels of phosphorylated ERK1/2 in castration resistant prostate cancer as compared to untreated primary prostate cancer. We observed that the presence of detectable phosphorylated ERK1/2 in the primary tumor is associated with biochemical failure after radical prostatectomy independent of clinicopathologic features. ERK1 is the immediate downstream target of MEK1/2, which is druggable with trametinib, an approved therapeutic for melanoma. Trametinib elicited a profound biochemical and clinical response in a patient who had failed multiple prior treatments for mCRPC.ConclusionsWe conclude that pharmacologic targeting of the MEK/ERK pathway may be a viable treatment strategy for patients with refractory metastatic prostate cancer. An ongoing Phase II trial tests this hypothesis.
- Published
- 2019
17. Performance of PCA3 and TMPRSS2:ERG urinary biomarkers in prediction of biopsy outcome in the Canary Prostate Active Surveillance Study (PASS)
- Author
-
Newcomb, Lisa F, Zheng, Yingye, Faino, Anna V, Bianchi-Frias, Daniella, Cooperberg, Matthew R, Brown, Marshall D, Brooks, James D, Dash, Atreya, Fabrizio, Michael D, Gleave, Martin E, Liss, Michael, Morgan, Todd M, Thompson, Ian M, Wagner, Andrew A, Carroll, Peter R, Nelson, Peter S, and Lin, Daniel W
- Subjects
Cancer ,Urologic Diseases ,Prostate Cancer ,Aging ,Clinical Research ,Prevention ,Aged ,Antigens ,Neoplasm ,Biomarkers ,Tumor ,Biopsy ,Humans ,Male ,Middle Aged ,Neoplasm Grading ,Prostate ,Prostatic Neoplasms ,ROC Curve ,Serine Endopeptidases ,Transcriptional Regulator ERG ,Watchful Waiting ,Oncology and Carcinogenesis ,Urology & Nephrology - Abstract
BackgroundFor men on active surveillance for prostate cancer, biomarkers may improve prediction of reclassification to higher grade or volume cancer. This study examined the association of urinary PCA3 and TMPRSS2:ERG (T2:ERG) with biopsy-based reclassification.MethodsUrine was collected at baseline, 6, 12, and 24 months in the multi-institutional Canary Prostate Active Surveillance Study (PASS), and PCA3 and T2:ERG levels were quantitated. Reclassification was an increase in Gleason score or ratio of biopsy cores with cancer to ≥34%. The association of biomarker scores, adjusted for common clinical variables, with short- and long-term reclassification was evaluated. Discriminatory capacity of models with clinical variables alone or with biomarkers was assessed using receiver operating characteristic (ROC) curves and decision curve analysis (DCA).ResultsSeven hundred and eighty-two men contributed 2069 urine specimens. After adjusting for PSA, prostate size, and ratio of biopsy cores with cancer, PCA3 but not T2:ERG was associated with short-term reclassification at the first surveillance biopsy (OR = 1.3; 95% CI 1.0-1.7, p = 0.02). The addition of PCA3 to a model with clinical variables improved area under the curve from 0.743 to 0.753 and increased net benefit minimally. After adjusting for clinical variables, neither marker nor marker kinetics was associated with time to reclassification in subsequent biopsies.ConclusionsPCA3 but not T2:ERG was associated with cancer reclassification in the first surveillance biopsy but has negligible improvement over clinical variables alone in ROC or DCA analyses. Neither marker was associated with reclassification in subsequent biopsies.
- Published
- 2019
18. Whole-Genome and Transcriptional Analysis of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer Demonstrates Intraclass Heterogeneity
- Author
-
Aggarwal, Rahul R, Quigley, David A, Huang, Jiaoti, Zhang, Li, Beer, Tomasz M, Rettig, Matthew B, Reiter, Rob E, Gleave, Martin E, Thomas, George V, Foye, Adam, Playdle, Denise, Lloyd, Paul, Chi, Kim N, Evans, Christopher P, Lara, Primo N, Feng, Felix Y, Alumkal, Joshi J, and Small, Eric J
- Subjects
Biological Sciences ,Biomedical and Clinical Sciences ,Genetics ,Clinical Sciences ,Oncology and Carcinogenesis ,Biotechnology ,Cancer ,Rare Diseases ,Prostate Cancer ,Urologic Diseases ,Human Genome ,Cancer Genomics ,Adenocarcinoma ,Biomarkers ,Tumor ,Biopsy ,Genome-Wide Association Study ,Humans ,Male ,Neuroendocrine Tumors ,Prostatic Neoplasms ,Castration-Resistant ,Receptors ,Androgen ,Transcription ,Genetic ,Developmental Biology ,Oncology & Carcinogenesis ,Biochemistry and cell biology ,Oncology and carcinogenesis - Abstract
Therapeutic resistance in metastatic castration-resistant prostate cancer (mCRPC) can be accompanied by treatment-emergent small-cell neuroendocrine carcinoma (t-SCNC), a morphologically distinct subtype. We performed integrative whole-genome and -transcriptome analysis of mCRPC tumor biopsies including paired biopsies after progression, and multiple samples from the same individual. t-SCNC was significantly less likely to have amplification of AR or an intergenic AR-enhancer locus, and demonstrated lower expression of AR and its downstream transcriptional targets. Genomic and transcriptional hallmarks of t-SCNC included biallelic loss of RB1, elevated expression levels of CDKN2A and E2F1, and loss of expression of the AR and AR-responsive genes including TMPRSS2 and NKX3-1. We identified three tumors that converted from adenocarcinoma to t-SCNC and demonstrate spatial and temporal intrapatient heterogeneity of metastatic tumors harboring adenocarcinoma, t-SCNC, or mixed expression phenotypes, with implications for treatment strategies in which dual targeting of adenocarcinoma and t-SCNC phenotypes may be necessary. IMPLICATIONS: The t-SCNC phenotype is characterized by lack of AR enhancer gain and loss of RB1 function, and demonstrates both interindividual and intraindividual heterogeneity.Visual Overview: http://mcr.aacrjournals.org/content/molcanres/17/6/1235/F1.large.jpg.
- Published
- 2019
19. The functions of clusterin in renal mesenchymal stromal cells: Promotion of cell growth and regulation of macrophage activation
- Author
-
Weng, Xiaodong, Li, Jing, Guan, Qiunong, Zhao, Haimei, Wang, Zihuan, Gleave, Martin E., Nguan, Christopher YC., and Du, Caigan
- Published
- 2022
- Full Text
- View/download PDF
20. Refined Analysis of Prostate-specific Antigen Kinetics to Predict Prostate Cancer Active Surveillance Outcomes
- Author
-
Cooperberg, Matthew R, Brooks, James D, Faino, Anna V, Newcomb, Lisa F, Kearns, James T, Carroll, Peter R, Dash, Atreya, Etzioni, Ruth, Fabrizio, Michael D, Gleave, Martin E, Morgan, Todd M, Nelson, Peter S, Thompson, Ian M, Wagner, Andrew A, Lin, Daniel W, and Zheng, Yingye
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Oncology and Carcinogenesis ,Cancer ,Bioengineering ,Prevention ,Clinical Research ,Aging ,Prostate Cancer ,Urologic Diseases ,Aged ,Biopsy ,Clinical Decision-Making ,Decision Support Techniques ,Disease Progression ,Humans ,Kallikreins ,Kinetics ,Male ,Middle Aged ,Neoplasm Grading ,North America ,Predictive Value of Tests ,Prospective Studies ,Prostate-Specific Antigen ,Prostatic Neoplasms ,Risk Assessment ,Risk Factors ,Tumor Burden ,Watchful Waiting ,Prostate-specific antigen ,Prostate cancer ,Active surveillance ,Outcomes ,Urology & Nephrology ,Clinical sciences - Abstract
BackgroundFor men on active surveillance for prostate cancer, utility of prostate-specific antigen (PSA) kinetics (PSAk) in predicting pathologic reclassification remains controversial.ObjectiveTo develop prediction methods for utilizing serial PSA and evaluate frequency of collection.Design, setting, and participantsData were collected from men enrolled in the multicenter Canary Prostate Active Surveillance Study, for whom PSA data were measured and biopsies performed on prespecified schedules. We developed a PSAk parameter based on a linear mixed-effect model (LMEM) that accounted for serial PSA levels.Outcome measurements and statistical analysisThe association of diagnostic PSA and/or PSAk with time to reclassification (increase in cancer grade and/or volume) was evaluated using multivariable Cox proportional hazards models.Results and limitationsA total of 851 men met the study criteria; 255 (30%) had a reclassification event within 5 yr. Median follow-up was 3.7 yr. After adjusting for prostate size, time since diagnosis, biopsy parameters, and diagnostic PSA, PSAk was a significant predictor of reclassification (hazard ratio for each 0.10 increase in PSAk=1.6 [95% confidence interval 1.2-2.1, p
- Published
- 2018
21. Role of Surveillance Biopsy with No Cancer as a Prognostic Marker for Reclassification: Results from the Canary Prostate Active Surveillance Study
- Author
-
Kearns, James T, Faino, Anna V, Newcomb, Lisa F, Brooks, James D, Carroll, Peter R, Dash, Atreya, Ellis, William J, Fabrizio, Michael, Gleave, Martin E, Morgan, Todd M, Nelson, Peter S, Thompson, Ian M, Wagner, Andrew A, Zheng, Yingye, and Lin, Daniel W
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Oncology and Carcinogenesis ,Aging ,Prostate Cancer ,Cancer ,Prevention ,Urologic Diseases ,Clinical Research ,Aged ,Asymptomatic Diseases ,Biomarkers ,Tumor ,Biopsy ,Needle ,Cohort Studies ,Humans ,Immunohistochemistry ,Kaplan-Meier Estimate ,Male ,Middle Aged ,Multivariate Analysis ,Neoplasm Grading ,Neoplasm Invasiveness ,Prognosis ,Proportional Hazards Models ,Prostate-Specific Antigen ,Prostatic Neoplasms ,Retrospective Studies ,Time Factors ,Watchful Waiting ,Active surveillance ,Prostate biopsy ,Prostate cancer ,Urology & Nephrology ,Clinical sciences - Abstract
BackgroundMany patients who are on active surveillance (AS) for prostate cancer will have surveillance prostate needle biopsies (PNBs) without any cancer evident.ObjectiveTo define the association between negative surveillance PNBs and risk of reclassification on AS.Design, setting, and participantsAll men were enrolled in the Canary Prostate Active Surveillance Study (PASS) between 2008 and 2016. Men were included if they had Gleason ≤3+4 prostate cancer and
- Published
- 2018
22. Reformation of the chondroitin sulfate glycocalyx enables progression of AR-independent prostate cancer
- Author
-
Al-Nakouzi, Nader, Wang, Chris Kedong, Oo, Htoo Zarni, Nelepcu, Irina, Lallous, Nada, Spliid, Charlotte B., Khazamipour, Nastaran, Lo, Joey, Truong, Sarah, Collins, Colin, Hui, Desmond, Esfandnia, Shaghayegh, Adomat, Hans, Clausen, Thomas Mandel, Gustavsson, Tobias, Choudhary, Swati, Dagil, Robert, Corey, Eva, Wang, Yuzhuo, Chauchereau, Anne, Fazli, Ladan, Esko, Jeffrey D., Salanti, Ali, Nelson, Peter S., Gleave, Martin E., and Daugaard, Mads
- Published
- 2022
- Full Text
- View/download PDF
23. Reply by Author
- Author
-
St-Laurent, Marie-Pier, primary, Acland, George, additional, Hamilton, Sarah N., additional, Hamm, Jeremy, additional, Sunderland, Katherine, additional, Black, Peter C., additional, McKenzie, Michael, additional, Keyes, Mira, additional, Miller, Stacy, additional, Gleave, Martin E., additional, and Tyldesley, Scott, additional
- Published
- 2024
- Full Text
- View/download PDF
24. CKB inhibits epithelial-mesenchymal transition and prostate cancer progression by sequestering and inhibiting AKT activation
- Author
-
Wang, Zheng, Hulsurkar, Mohit, Zhuo, Lijuan, Xu, Jinbang, Yang, Han, Naderinezhad, Samira, Wang, Lin, Zhang, Guoliang, Ai, Nanping, Li, Linna, Chang, Jeffrey T., Zhang, Songlin, Fazli, Ladan, Creighton, Chad J., Bai, Fang, Ittmann, Michael M., Gleave, Martin E., and Li, Wenliang
- Published
- 2021
- Full Text
- View/download PDF
25. Boolean analysis identifies CD38 as a biomarker of aggressive localized prostate cancer
- Author
-
Sahoo, Debashis, Wei, Wei, Auman, Heidi, Hurtado-Coll, Antonio, Carroll, Peter R, Fazli, Ladan, Gleave, Martin E, Lin, Daniel W, Nelson, Peter S, Simko, Jeff, Thompson, Ian M, Leach, Robin J, Troyer, Dean A, True, Lawrence D, McKenney, Jesse K, Feng, Ziding, and Brooks, James D
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Oncology and Carcinogenesis ,Aging ,Urologic Diseases ,Clinical Research ,Prevention ,Cancer ,Prostate Cancer ,4.1 Discovery and preclinical testing of markers and technologies ,ARG2 ,CD38 ,Prognosis ,Prostate cancer ,biochemical recurrence ,Oncology and carcinogenesis - Abstract
The introduction of serum Prostate Specific Antigen (PSA) testing nearly 30 years ago has been associated with a significant shift towards localized disease and decreased deaths due to prostate cancer. Recognition that PSA testing has caused over diagnosis and over treatment of prostate cancer has generated considerable controversy over its value, and has spurred efforts to identify prognostic biomarkers to distinguish patients who need treatment from those that can be observed. Recent studies show that cancer is heterogeneous and forms a hierarchy of tumor cell populations. We developed a method of identifying prostate cancer differentiation states related to androgen signaling using Boolean logic. Using gene expression data, we identified two markers, CD38 and ARG2, that group prostate cancer into three differentiation states. Cancers with CD38-, ARG2- expression patterns, corresponding to an undifferentiated state, had significantly lower 10-year recurrence-free survival compared to the most differentiated group (CD38+ARG2+). We carried out immunohistochemical (IHC) staining for these two markers in a single institution (Stanford; n = 234) and multi-institution (Canary; n = 1326) cohorts. IHC staining for CD38 and ARG2 in the Stanford cohort demonstrated that combined expression of CD38 and ARG2 was prognostic. In the Canary cohort, low CD38 protein expression by IHC was significantly associated with recurrence-free survival (RFS), seminal vesicle invasion (SVI), extra-capsular extension (ECE) in univariable analysis. In multivariable analysis, ARG2 and CD38 IHC staining results were not independently associated with RFS, overall survival, or disease-specific survival after adjusting for other factors including SVI, ECE, Gleason score, pre-operative PSA, and surgical margins.
- Published
- 2018
26. Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer.
- Author
-
Wyatt, Alexander W, Annala, Matti, Aggarwal, Rahul, Beja, Kevin, Feng, Felix, Youngren, Jack, Foye, Adam, Lloyd, Paul, Nykter, Matti, Beer, Tomasz M, Alumkal, Joshi J, Thomas, George V, Reiter, Robert E, Rettig, Matthew B, Evans, Christopher P, Gao, Allen C, Chi, Kim N, Small, Eric J, and Gleave, Martin E
- Subjects
Genetics ,Cancer ,Human Genome ,Urologic Diseases ,Prostate Cancer ,4.1 Discovery and preclinical testing of markers and technologies ,Detection ,screening and diagnosis ,Good Health and Well Being ,Adenomatous Polyposis Coli Protein ,BRCA2 Protein ,Biomarkers ,Tumor ,Circulating Tumor DNA ,Class Ia Phosphatidylinositol 3-Kinase ,Cyclin-Dependent Kinase Inhibitor p27 ,DNA Copy Number Variations ,Humans ,Liquid Biopsy ,Male ,Mutation ,Neoplasm Metastasis ,Nuclear Proteins ,PTEN Phosphohydrolase ,Phosphatidylinositol 3-Kinases ,Prostatic Neoplasms ,Castration-Resistant ,Receptors ,Androgen ,Repressor Proteins ,Retinoblastoma Binding Proteins ,Tumor Suppressor Protein p53 ,Ubiquitin-Protein Ligases ,Wnt Signaling Pathway ,Oncology and Carcinogenesis ,Oncology & Carcinogenesis - Abstract
Real-time knowledge of the somatic genome can influence management of patients with metastatic castration-resistant prostate cancer (mCRPC). While routine metastatic tissue biopsy is challenging in mCRPC, plasma circulating tumor DNA (ctDNA) has emerged as a minimally invasive tool to sample the tumor genome. However, no systematic comparisons of matched "liquid" and "solid" biopsies have been performed that would enable ctDNA profiling to replace the need for direct tissue sampling. We performed targeted sequencing across 72 clinically relevant genes in 45 plasma cell-free DNA (cfDNA) samples collected at time of metastatic tissue biopsy. We compared ctDNA alterations with exome sequencing data generated from matched tissue and quantified the concordance of mutations and copy number alterations using the Fisher exact test and Pearson correlations. Seventy-five point six percent of cfDNA samples had a ctDNA proportion greater than 2% of total cfDNA. In these patients, all somatic mutations identified in matched metastatic tissue biopsies were concurrently present in ctDNA. Furthermore, the hierarchy of variant allele fractions for shared mutations was remarkably similar between ctDNA and tissue. Copy number profiles between matched liquid and solid biopsy were highly correlated, and individual copy number calls in clinically actionable genes were 88.9% concordant. Detected alterations included AR amplifications in 22 (64.7%) samples, SPOP mutations in three (8.8%) samples, and inactivating alterations in tumor suppressors TP53 , PTEN , RB1 , APC , CDKN1B , BRCA2 , and PIK3R1 . In several patients, ctDNA sequencing revealed robust changes not present in paired solid biopsy, including clinically relevant alterations in the AR, WNT, and PI3K pathways. Our study shows that, in the majority of patients, a ctDNA assay is sufficient to identify all driver DNA alterations present in matched metastatic tissue and supports development of DNA biomarkers to guide mCRPC patient management based on ctDNA alone.
- Published
- 2017
27. Evaluating the Four Kallikrein Panel of the 4Kscore for Prediction of High-grade Prostate Cancer in Men in the Canary Prostate Active Surveillance Study.
- Author
-
Lin, Daniel W, Newcomb, Lisa F, Brown, Marshall D, Sjoberg, Daniel D, Dong, Yan, Brooks, James D, Carroll, Peter R, Cooperberg, Matthew, Dash, Atreya, Ellis, William J, Fabrizio, Michael, Gleave, Martin E, Morgan, Todd M, Nelson, Peter S, Thompson, Ian M, Wagner, Andrew A, Zheng, Yingye, and Canary Prostate Active Surveillance Study Investigators
- Subjects
Canary Prostate Active Surveillance Study Investigators ,Humans ,Prostatic Neoplasms ,Kallikreins ,Prostate-Specific Antigen ,Biopsy ,Area Under Curve ,Odds Ratio ,Risk Assessment ,Risk Factors ,Prospective Studies ,Reproducibility of Results ,Predictive Value of Tests ,ROC Curve ,Algorithms ,Decision Support Techniques ,Aged ,Middle Aged ,North America ,Male ,Watchful Waiting ,Neoplasm Grading ,Active surveillance ,Biomarker ,Kallikrein ,Prospective studies ,Prostatic neoplasms ,Aging ,Cancer ,Prostate Cancer ,Clinical Research ,Urologic Diseases ,Detection ,screening and diagnosis ,4.2 Evaluation of markers and technologies ,Clinical Sciences ,Urology & Nephrology - Abstract
BackgroundDiagnosis of Gleason 6 prostate cancer can leave uncertainty about the presence of undetected aggressive disease.ObjectiveTo evaluate the utility of a four kallikrein (4K) panel in predicting the presence of high-grade cancer in men on active surveillance.Design, setting, and participantsPlasma collected before the first and subsequent surveillance biopsies was assessed for 718 men prospectively enrolled in the multi-institutional Canary PASS trial. Biopsy data were split 2:1 into training and test sets. We developed statistical models that included clinical information and either the 4Kpanel or serum prostate-specific antigen (PSA).Outcome measurements and statistical analysisThe endpoint was reclassification to Gleason ≥7. We used receiver operating characteristic (ROC) curve analyses and area under the curve (AUC) to assess discriminatory capacity, and decision curve analysis (DCA) to report clinical net benefit.Results and limitationsSignificant predictors for reclassification were 4Kpanel (odds ratio [OR] 1.54, 95% confidence interval [CI] 1.31-1.81) or PSA (OR 2.11, 95% CI 1.53-2.91), ≥20% cores positive (OR 2.10, 95% CI 1.33-3.32), two or more prior negative biopsies (OR 0.19, 95% CI 0.04-0.85), prostate volume (OR 0.47, 95% CI 0.31-0.70), and body mass index (OR 1.09, 95% CI 1.04-1.14). ROC curve analysis comparing 4K and base models indicated that the 4Kpanel improved accuracy for predicting reclassification (AUC 0.78 vs 0.74) at the first surveillance biopsy. Both models performed comparably for prediction of reclassification at subsequent biopsies (AUC 0.75 vs 0.76). In DCA, both models showed higher net benefit compared to biopsy-all and biopsy-none strategies. Limitations include the single cohort nature of the study and the small numbers; results should be validated in another cohort before clinical use.ConclusionsThe 4Kpanel provided incremental value over routine clinical information in predicting high-grade cancer in the first biopsy after diagnosis. The 4Kpanel did not add predictive value to the base model at subsequent surveillance biopsies.Patient summaryActive surveillance is a management strategy for many low-grade prostate cancers. Repeat biopsies monitor for previously undetected high-grade cancer. We show that a model with clinical variables, including a panel of four kallikreins, indicates the presence of high-grade cancer before a biopsy is performed.
- Published
- 2017
28. Timing of Adverse Prostate Cancer Reclassification on First Surveillance Biopsy: Results from the Canary Prostate Cancer Active Surveillance Study
- Author
-
Macleod, Liam C, Ellis, William J, Newcomb, Lisa F, Zheng, Yingye, Brooks, James D, Carroll, Peter R, Gleave, Martin E, Lance, Raymond S, Nelson, Peter S, Thompson, Ian M, Wagner, Andrew A, Wei, John T, and Lin, Daniel W
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Oncology and Carcinogenesis ,Cancer ,Urologic Diseases ,Clinical Research ,Aging ,Prostate Cancer ,Prevention ,Aged ,Biopsy ,Humans ,Male ,Middle Aged ,Prospective Studies ,Prostate ,Prostatic Neoplasms ,Time Factors ,Watchful Waiting ,prostatic neoplasms ,prostate specific antigen ,body mass index ,biopsy ,watchful waiting ,Urology & Nephrology ,Clinical sciences - Abstract
PurposeDuring active surveillance for localized prostate cancer, the timing of the first surveillance biopsy varies. We analyzed the Canary PASS (Prostate Cancer Active Surveillance Study) to determine biopsy timing influence on rates of prostate cancer adverse reclassification at the first active surveillance biopsy.Materials and methodsOf 1,085 participants in PASS, 421 had fewer than 34% of cores involved with cancer and Gleason sum 6 or less, and thereafter underwent on-study active surveillance biopsy. Reclassification was defined as an increase in Gleason sum and/or 34% or more of cores with prostate cancer. First active surveillance biopsy reclassification rates were categorized as less than 8, 8 to 13 and greater than 13 months after diagnosis. Multivariable logistic regression determined association between reclassification and first biopsy timing.ResultsOf 421 men, 89 (21.1%) experienced reclassification at the first active surveillance biopsy. Median time from prostate cancer diagnosis to first active surveillance biopsy was 11 months (IQR 7.8-13.8). Reclassification rates at less than 8, 8 to 13 and greater than 13 months were 24%, 19% and 22% (p = 0.65). On multivariable analysis, compared to men biopsied at less than 8 months the OR of reclassification at 8 to 13 and greater than 13 months were 0.88 (95% CI 0.5,1.6) and 0.95 (95% CI 0.5,1.9), respectively. Prostate specific antigen density 0.15 or greater (referent less than 0.15, OR 1.9, 95% CI 1.1, 4.1) and body mass index 35 kg/m2 or greater (referent less than 25 kg/m2, OR 2.4, 95% CI 1.1,5.7) were associated with increased odds of reclassification.ConclusionsTiming of the first active surveillance biopsy was not associated with increased adverse reclassification but prostate specific antigen density and body mass index were. In low risk patients on active surveillance, it may be reasonable to perform the first active surveillance biopsy at a later time, reducing the overall cost and morbidity of active surveillance.
- Published
- 2017
29. Activating AKT1 and PIK3CA Mutations in Metastatic Castration-Resistant Prostate Cancer
- Author
-
Herberts, Cameron, Murtha, Andrew J., Fu, Simon, Wang, Gang, Schönlau, Elena, Xue, Hui, Lin, Dong, Gleave, Anna, Yip, Steven, Angeles, Arkhjamil, Hotte, Sebastien, Tran, Ben, North, Scott, Taavitsainen, Sinja, Beja, Kevin, Vandekerkhove, Gillian, Ritch, Elie, Warner, Evan, Saad, Fred, Iqbal, Nayyer, Nykter, Matti, Gleave, Martin E., Wang, Yuzhuo, Annala, Matti, Chi, Kim N., and Wyatt, Alexander W.
- Published
- 2020
- Full Text
- View/download PDF
30. Small Renal Mass Surveillance: Histology-specific Growth Rates in a Biopsy-characterized Cohort
- Author
-
Finelli, Antonio, Cheung, Douglas C., Al-Matar, Ashraf, Evans, Andrew J., Morash, Christopher G., Pautler, Stephen E., Siemens, D. Robert, Tanguay, Simon, Rendon, Ricardo A., Gleave, Martin E., Drachenberg, Darrel E., Chin, Joseph L., Fleshner, Neil E., Haider, Masoom A., Kachura, John R., Sykes, Jenna, and Jewett, Michael A.S.
- Published
- 2020
- Full Text
- View/download PDF
31. Plasma Circulating Tumor DNA and Clonal Hematopoiesis in Metastatic Renal Cell Carcinoma
- Author
-
Bacon, Jack V.W., Annala, Matti, Soleimani, Maryam, Lavoie, Jean-Michel, So, Alan, Gleave, Martin E., Fazli, Ladan, Wang, Gang, Chi, Kim N., Kollmannsberger, Christian K., Wyatt, Alexander W., and Nappi, Lucia
- Published
- 2020
- Full Text
- View/download PDF
32. Cancer Cells Employ Nuclear Caspase-8 to Overcome the p53-Dependent G2/M Checkpoint through Cleavage of USP28
- Author
-
Müller, Ines, Strozyk, Elwira, Schindler, Sebastian, Beissert, Stefan, Oo, Htoo Zarni, Sauter, Thomas, Lucarelli, Philippe, Raeth, Sebastian, Hausser, Angelika, Al Nakouzi, Nader, Fazli, Ladan, Gleave, Martin E., Liu, He, Simon, Hans-Uwe, Walczak, Henning, Green, Douglas R., Bartek, Jiri, Daugaard, Mads, and Kulms, Dagmar
- Published
- 2020
- Full Text
- View/download PDF
33. Long Term Second Malignancies in Prostate Cancer Patients Treated with Low-Dose-Rate Brachytherapy and Radical Prostatectomy
- Author
-
St-Laurent, Marie-Pier, primary, Acland, George, additional, Hamilton, Sarah N., additional, Hamm, Jeremy, additional, Sunderland, Katherine, additional, Black, Peter C., additional, McKenzie, Michael, additional, Keyes, Mira, additional, Miller, Stacy, additional, Gleave, Martin E., additional, and Tyldesley, Scott, additional
- Published
- 2024
- Full Text
- View/download PDF
34. A novel type-2 innate lymphoid cell-based immunotherapy for cancer
- Author
-
Saranchova, Iryna, primary, Xia, Clara Wenjing, additional, Besoiu, Stephanie, additional, Finkel, Pablo L., additional, Ellis, Samantha L. S., additional, Kari, Suresh, additional, Munro, Lonna, additional, Pfeifer, Cheryl G., additional, Fazli, Ladan, additional, Gleave, Martin E., additional, and Jefferies, Wilfred A., additional
- Published
- 2024
- Full Text
- View/download PDF
35. Loss of Expression of AZGP1 Is Associated With Worse Clinical Outcomes in a Multi-Institutional Radical Prostatectomy Cohort.
- Author
-
Brooks, James D, Wei, Wei, Pollack, Jonathan R, West, Robert B, Shin, Jun Ho, Sunwoo, John B, Hawley, Sarah J, Auman, Heidi, Newcomb, Lisa F, Simko, Jeff, Hurtado-Coll, Antonio, Troyer, Dean A, Carroll, Peter R, Gleave, Martin E, Lin, Daniel W, Nelson, Peter S, Thompson, Ian M, True, Lawrence D, McKenney, Jesse K, Feng, Ziding, and Fazli, Ladan
- Subjects
Humans ,Prostatic Neoplasms ,Neoplasm Recurrence ,Local ,Glycoproteins ,Carrier Proteins ,Prognosis ,Treatment Outcome ,Prostatectomy ,Tissue Array Analysis ,Survival Analysis ,Case-Control Studies ,Random Allocation ,Male ,Biomarkers ,Tumor ,AZGP1 ,immunohistochemistry ,prognosis ,prostate cancer ,Adipokines ,Prostate Cancer ,Cancer ,Clinical Research ,Biotechnology ,Urologic Diseases ,Clinical Sciences ,Oncology and Carcinogenesis ,Paediatrics and Reproductive Medicine ,Oncology & Carcinogenesis - Abstract
BackgroundGiven the uncertainties inherent in clinical measures of prostate cancer aggressiveness, clinically validated tissue biomarkers are needed. We tested whether Alpha-2-Glycoprotein 1, Zinc-Binding (AZGP1) protein levels, measured by immunohistochemistry, and RNA expression, by RNA in situ hybridization (RISH), predict recurrence after radical prostatectomy independent of clinical and pathological parameters.MethodsAZGP1 IHC and RISH were performed on a large multi-institutional tissue microarray resource including 1,275 men with 5 year median follow-up. The relationship between IHC and RISH expression levels was assessed using the Kappa analysis. Associations with clinical and pathological parameters were tested by the Chi-square test and the Wilcoxon rank sum test. Relationships with outcome were assessed with univariable and multivariable Cox proportional hazards models and the Log-rank test.ResultsAbsent or weak expression of AZGP1 protein was associated with worse recurrence free survival (RFS), disease specific survival, and overall survival after radical prostatectomy in univariable analysis. AZGP1 protein expression, along with pre-operative serum PSA levels, surgical margin status, seminal vesicle invasion, extracapsular extension, and Gleason score predicted RFS on multivariable analysis. Similarly, absent or low AZGP1 RNA expression by RISH predicted worse RFS after prostatectomy in univariable and multivariable analysis.ConclusionsIn our large, rigorously designed validation cohort, loss of AZGP1 expression predicts RFS after radical prostatectomy independent of clinical and pathological variables. Prostate 76:1409-1419, 2016. © 2016 Wiley Periodicals, Inc.
- Published
- 2016
36. Treatment of the Primary Tumor in Metastatic Prostate Cancer: Current Concepts and Future Perspectives
- Author
-
Bayne, Christopher E, Williams, Stephen B, Cooperberg, Matthew R, Gleave, Martin E, Graefen, Markus, Montorsi, Francesco, Novara, Giacomo, Smaldone, Marc C, Sooriakumaran, Prasanna, Wiklund, Peter N, and Chapin, Brian F
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Oncology and Carcinogenesis ,Prostate Cancer ,Clinical Trials and Supportive Activities ,Urologic Diseases ,Clinical Research ,Cancer ,Aging ,6.1 Pharmaceuticals ,Evaluation of treatments and therapeutic interventions ,Antineoplastic Agents ,Combined Modality Therapy ,Cytoreduction Surgical Procedures ,Humans ,Lymph Node Excision ,Lymphatic Metastasis ,Male ,Prostatectomy ,Prostatic Neoplasms ,Radiotherapy ,Risk Assessment ,Prostatic neoplasms ,Neoplasm metastasis ,Chemotherapy ,Survival ,Urology & Nephrology ,Clinical sciences - Abstract
ContextMultimodal treatment for men with locally advanced prostate cancer (PCa) using neoadjuvant/adjuvant systemic therapy, surgery, and radiation therapy is being increasingly explored. There is also interest in the oncologic benefit of treating the primary tumor in the setting of metastatic PCa (mPCa).ObjectiveTo perform a review of the literature regarding the treatment of the primary tumor in the setting of mPCa.Evidence acquisitionMedline, PubMed, and Scopus electronic databases were queried for English language articles from January 1990 to September 2014. Prospective and retrospective studies were included.Evidence synthesisThere is no published randomized controlled trial (RCT) comparing local therapy and systemic therapy to systemic therapy alone in the treatment of mPCa. Prospective studies of men with locally advanced PCa and retrospective studies of occult node-positive PCa have consistently shown the addition of local therapy to a multimodal treatment regimen improves outcomes. Molecular and genomic evidence further suggests the primary tumor may have an active role in mPCa.ConclusionsTreatment of the primary tumor in mPCa is being increasingly explored. While preclinical, translational, and retrospective evidence supports local therapy in advanced disease, further prospective studies are under way to evaluate this multimodal approach and identify the patients most likely to benefit from the inclusion of local therapy in the setting of metastatic disease.Patient summaryIn this review we explored preclinical and clinical evidence for treatment of the primary tumor in metastatic prostate cancer (mPCa). We found evidence to support clinical trials investigating mPCa therapy that includes local treatment of the primary tumor. Currently, treating the primary tumor in mPCa is controversial and lacks high-level evidence sufficient for routine recommendation.
- Published
- 2016
37. Outcomes of Active Surveillance for Clinically Localized Prostate Cancer in the Prospective, Multi-Institutional Canary PASS Cohort.
- Author
-
Newcomb, Lisa F, Thompson, Ian M, Boyer, Hilary D, Brooks, James D, Carroll, Peter R, Cooperberg, Matthew R, Dash, Atreya, Ellis, William J, Fazli, Ladan, Feng, Ziding, Gleave, Martin E, Kunju, Priya, Lance, Raymond S, McKenney, Jesse K, Meng, Maxwell V, Nicolas, Marlo M, Sanda, Martin G, Simko, Jeffry, So, Alan, Tretiakova, Maria S, Troyer, Dean A, True, Lawrence D, Vakar-Lopez, Funda, Virgin, Jeff, Wagner, Andrew A, Wei, John T, Zheng, Yingye, Nelson, Peter S, Lin, Daniel W, and Canary PASS Investigators
- Subjects
Canary PASS Investigators ,Humans ,Prostatic Neoplasms ,Biopsy ,Treatment Outcome ,Prostatectomy ,Tumor Burden ,Population Surveillance ,Risk Factors ,Prospective Studies ,Aged ,Middle Aged ,Male ,Watchful Waiting ,Neoplasm Grading ,Biomarkers ,Tumor ,prospective studies ,prostatic neoplasms ,watchful waiting ,Clinical Research ,Urologic Diseases ,Prostate Cancer ,Cancer ,Prevention ,Aging ,Patient Safety ,Clinical Sciences ,Urology & Nephrology - Abstract
PurposeActive surveillance represents a strategy to address the overtreatment of prostate cancer, yet uncertainty regarding individual patient outcomes remains a concern. We evaluated outcomes in a prospective multicenter study of active surveillance.Materials and methodsWe studied 905 men in the prospective Canary PASS enrolled between 2008 and 2013. We collected clinical data at study entry and at prespecified intervals, and determined associations with adverse reclassification, defined as increased Gleason grade or greater cancer volume on followup biopsy. We also evaluated the relationships of clinical parameters with pathology findings in participants who underwent surgery after a period of active surveillance.ResultsAt a median followup of 28 months 24% of participants experienced adverse reclassification, of whom 53% underwent treatment while 31% continued on active surveillance. Overall 19% of participants received treatment, 68% with adverse reclassification, while 32% opted for treatment without disease reclassification. In multivariate Cox proportional hazards modeling the percent of biopsy cores with cancer, body mass index and prostate specific antigen density were associated with adverse reclassification (p=0.01, 0.04, 0.04, respectively). Of 103 participants subsequently treated with radical prostatectomy 34% had adverse pathology, defined as primary pattern 4-5 or nonorgan confined disease, including 2 with positive lymph nodes, with no significant relationship between risk category at diagnosis and findings at surgery (p=0.76).ConclusionsMost men remain on active surveillance at 5 years without adverse reclassification or adverse pathology at surgery. However, clinical factors had only a modest association with disease reclassification, supporting the need for approaches that improve the prediction of this outcome.
- Published
- 2016
38. THEM6‐mediated reprogramming of lipid metabolism supports treatment resistance in prostate cancer
- Author
-
Blomme, Arnaud, Peter, Coralie, Mui, Ernest, Rodriguez Blanco, Giovanny, An, Ning, Mason, Louise M, Jamieson, Lauren E, McGregor, Grace H, Lilla, Sergio, Ntala, Chara, Patel, Rachana, Thiry, Marc, Kung, Sonia H Y, Leclercq, Marine, Ford, Catriona A, Rushworth, Linda K, McGarry, David J, Mason, Susan, Repiscak, Peter, Nixon, Colin, Salji, Mark J, Markert, Elke, MacKay, Gillian M, Kamphorst, Jurre J, Graham, Duncan, Faulds, Karen, Fazli, Ladan, Gleave, Martin E, Avezov, Edward, Edwards, Joanne, Yin, Huabing, Sumpton, David, Blyth, Karen, Close, Pierre, Murphy, Daniel J, Zanivan, Sara, and Leung, Hing Y
- Published
- 2022
- Full Text
- View/download PDF
39. LIN28B promotes the development of neuroendocrine prostate cancer
- Author
-
Lovnicki, Jessica, Gan, Yu, Feng, Tingting, Li, Yinan, Xie, Ning, Ho, Chia-Hao, Lee, Ahn R., Chen, Xufeng, Nappi, Lucia, Han, Bo, Fazli, Ladan, Huang, Jiaoti, Gleave, Martin E., and Dong, Xuesen
- Subjects
Genetic engineering -- Health aspects -- Analysis ,Enzalutamide -- Health aspects -- Analysis ,Abiraterone -- Analysis -- Health aspects ,Genes -- Analysis -- Health aspects ,Prostate cancer -- Development and progression ,Stem cells -- Health aspects -- Analysis ,Chromosomal proteins -- Analysis -- Health aspects ,Health care industry - Abstract
Therapy-induced neuroendocrine prostate cancer (t-NEPC) is a highly aggressive subtype of prostate cancer with poor patient survival. Emerging evidence indicates that t-NEPC can develop when prostate adenocarcinoma cells acquire cancer stem-like cell signaling in the presence of androgen receptor inhibition, followed by redifferentiation toward neuroendocrine lineage and subsequent t-NEPC progression. Whether the stem-like signaling is controlled by the core pluripotency stem cell genes (e.g., LIN28 and SOX2) remains unknown. Here, we report that the transcription of the LIN28B isoform and SOX2 were co-upregulated in t-NEPC patient tumors, patient-derived xenografts, transgenic mice, and cell models. Immunohistochemistry validated that LIN28B and SOX2 protein expression were elevated in t-NEPC patient biopsies. Using prostate adenocarcinoma and t-NEPC cell models, we demonstrated that LIN28B induced a stem-like gene network, neuroendocrine biomarkers, and neuroendocrine cell morphology. LIN28B depletion by CRISPR inhibited t-NEPC tumorigenesis and xenograft growth. These LIN28B functions were mediated mainly through the suppression of let-7 miRNA expression, resulting in de-repression of the transcription factor HMGA2 and HMGA2-mediated SOX2 expression. This study revealed a mechanism by which t-NEPC can develop through the LIN28B/let-7/SOX2 axis that regulates a cancer cell stem-like gene network, highlighting LIN28B as a potential therapeutic target in t-NEPC., Introduction New, potent androgen receptor (AR) pathway inhibitors (ARPIs) have improved overall survival in men with metastatic prostate cancer (PCa) (1, 2). However, more aggressive subtypes of castrate-resistant prostate cancer [...]
- Published
- 2020
- Full Text
- View/download PDF
40. MUC1 Expression by Immunohistochemistry Is Associated with Adverse Pathologic Features in Prostate Cancer: A Multi-Institutional Study.
- Author
-
Eminaga, Okyaz, Wei, Wei, Hawley, Sarah J, Auman, Heidi, Newcomb, Lisa F, Simko, Jeff, Hurtado-Coll, Antonio, Troyer, Dean A, Carroll, Peter R, Gleave, Martin E, Lin, Daniel W, Nelson, Peter S, Thompson, Ian M, True, Lawrence D, McKenney, Jesse K, Feng, Ziding, Fazli, Ladan, and Brooks, James D
- Subjects
Humans ,Prostatic Neoplasms ,Disease-Free Survival ,Treatment Outcome ,Prostatectomy ,Immunohistochemistry ,Multivariate Analysis ,Proportional Hazards Models ,Adult ,Aged ,Aged ,80 and over ,Middle Aged ,Male ,Mucin-1 ,Patient Safety ,Prostate Cancer ,Urologic Diseases ,Aging ,Cancer ,General Science & Technology - Abstract
BackgroundThe uncertainties inherent in clinical measures of prostate cancer (CaP) aggressiveness endorse the investigation of clinically validated tissue biomarkers. MUC1 expression has been previously reported to independently predict aggressive localized prostate cancer. We used a large cohort to validate whether MUC1 protein levels measured by immunohistochemistry (IHC) predict aggressive cancer, recurrence and survival outcomes after radical prostatectomy independent of clinical and pathological parameters.Material and methodsMUC1 IHC was performed on a multi-institutional tissue microarray (TMA) resource including 1,326 men with a median follow-up of 5 years. Associations with clinical and pathological parameters were tested by the Chi-square test and the Wilcoxon rank sum test. Relationships with outcome were assessed with univariable and multivariable Cox proportional hazard models and the Log-rank test.ResultsThe presence of MUC1 expression was significantly associated with extracapsular extension and higher Gleason score, but not with seminal vesicle invasion, age, positive surgical margins or pre-operative serum PSA levels. In univariable analyses, positive MUC1 staining was significantly associated with a worse recurrence free survival (RFS) (HR: 1.24, CI 1.03-1.49, P = 0.02), although not with disease specific survival (DSS, P>0.5). On multivariable analyses, the presence of positive surgical margins, extracapsular extension, seminal vesicle invasion, as well as higher pre-operative PSA and increasing Gleason score were independently associated with RFS, while MUC1 expression was not. Positive MUC1 expression was not independently associated with disease specific survival (DSS), but was weakly associated with overall survival (OS).ConclusionIn our large, rigorously designed validation cohort, MUC1 protein expression was associated with adverse pathological features, although it was not an independent predictor of outcome after radical prostatectomy.
- Published
- 2016
41. A polymeric paste-drug formulation for intratumoral treatment of prostate cancer
- Author
-
Kesch, Claudia, Schmitt, Veronika, Bidnur, Samir, Thi, Marisa, Beraldi, Eliana, Moskalev, Igor, Yago, Virginia, Bowden, Mary, Adomat, Hans, Fazil, Ladan, Jackson, John K., and Gleave, Martin E.
- Published
- 2020
- Full Text
- View/download PDF
42. Predicting complications following radical cystectomy with the ACS NSQIP universal surgical risk calculator
- Author
-
Mannas, Miles P., Lee, Taeweon, Forbes, Connor M., Hong, Tracey, Bisaillon, Andrea, Gleave, Martin E., So, Alan I., Mayson, Kelly, and Black, Peter C.
- Published
- 2020
- Full Text
- View/download PDF
43. Precision Medicine in Active Surveillance for Prostate Cancer: Development of the Canary–Early Detection Research Network Active Surveillance Biopsy Risk Calculator
- Author
-
Ankerst, Donna P, Xia, Jing, Thompson, Ian M, Hoefler, Josef, Newcomb, Lisa F, Brooks, James D, Carroll, Peter R, Ellis, William J, Gleave, Martin E, Lance, Raymond S, Nelson, Peter S, Wagner, Andrew A, Wei, John T, Etzioni, Ruth, and Lin, Daniel W
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Oncology and Carcinogenesis ,Prevention ,Clinical Research ,Aging ,Urologic Diseases ,Cancer ,Prostate Cancer ,Detection ,screening and diagnosis ,4.2 Evaluation of markers and technologies ,Good Health and Well Being ,Aged ,Aged ,80 and over ,Biomedical Research ,Biopsy ,Early Detection of Cancer ,Humans ,Male ,Middle Aged ,Precision Medicine ,Prospective Studies ,Prostatic Neoplasms ,Risk Assessment ,Watchful Waiting ,Active surveillance ,Progression ,Prostate-specific antigen ,Urology & Nephrology ,Clinical sciences - Abstract
BackgroundMen on active surveillance (AS) face repeated biopsies. Most biopsy specimens will not show disease progression or change management. Such biopsies do not contribute to patient management and are potentially morbid and costly.ObjectiveTo use a contemporary AS prospective trial to develop a tool to predict AS biopsy outcomes.Design, setting, and participantsBiopsy samples (median: 2; range: 2-9 per patient) from 859 men participating in the Canary Prostate Active Surveillance Study and with Gleason 6 prostate cancer (median follow-up: 35.8 mo; range: 3.0-148.7 mo) were analyzed.Outcome measurements and statistical analysisLogistic regression was used to predict progression, defined as an increase in Gleason score from ≤6 to ≥7 or increase in percentage of cores positive for cancer from
- Published
- 2015
44. Functional mapping of androgen receptor enhancer activity
- Author
-
Huang, Chia-Chi Flora, Lingadahalli, Shreyas, Morova, Tunc, Ozturan, Dogancan, Hu, Eugene, Yu, Ivan Pak Lok, Linder, Simon, Hoogstraat, Marlous, Stelloo, Suzan, Sar, Funda, van der Poel, Henk, Altintas, Umut Berkay, Saffarzadeh, Mohammadali, Le Bihan, Stephane, McConeghy, Brian, Gokbayrak, Bengul, Feng, Felix Y., Gleave, Martin E., Bergman, Andries M., Collins, Colin, Hach, Faraz, Zwart, Wilbert, Emberly, Eldon, and Lack, Nathan A.
- Published
- 2021
- Full Text
- View/download PDF
45. A noncanonical AR addiction drives enzalutamide resistance in prostate cancer
- Author
-
He, Yundong, Wei, Ting, Ye, Zhenqing, Orme, Jacob J., Lin, Dong, Sheng, Haoyue, Fazli, Ladan, Jeffrey Karnes, R., Jimenez, Rafael, Wang, Liguo, Wang, Liewei, Gleave, Martin E., Wang, Yuzhuo, Shi, Lei, and Huang, Haojie
- Published
- 2021
- Full Text
- View/download PDF
46. Optimal sequencing of enzalutamide and abiraterone acetate plus prednisone in metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase 2, crossover trial
- Author
-
Khalaf, Daniel J, Annala, Matti, Taavitsainen, Sinja, Finch, Daygen L, Oja, Conrad, Vergidis, Joanna, Zulfiqar, Muhammad, Sunderland, Katherine, Azad, Arun A, Kollmannsberger, Christian K, Eigl, Bernhard J, Noonan, Krista, Wadhwa, Deepa, Attwell, Andrew, Keith, Bruce, Ellard, Susan L, Le, Lyly, Gleave, Martin E, Wyatt, Alexander W, and Chi, Kim N
- Published
- 2019
- Full Text
- View/download PDF
47. Health-related Quality of Life for Abiraterone Plus Prednisone Versus Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer: Results from a Phase II Randomized Trial
- Author
-
Khalaf, Daniel J., Sunderland, Katherine, Eigl, Bernhard J., Kollmannsberger, Christian K., Ivanov, Nikita, Finch, Daygen L., Oja, Conrad, Vergidis, Joanna, Zulfiqar, Muhammad, Gleave, Martin E., and Chi, Kim N.
- Published
- 2019
- Full Text
- View/download PDF
48. Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate Cancer
- Author
-
Vandekerkhove, Gillian, Struss, Werner J., Annala, Matti, Kallio, Heini M.L., Khalaf, Daniel, Warner, Evan W., Herberts, Cameron, Ritch, Elie, Beja, Kevin, Loktionova, Yulia, Hurtado-Coll, Antonio, Fazli, Ladan, So, Alan, Black, Peter C., Nykter, Matti, Tammela, Teuvo, Chi, Kim N., Gleave, Martin E., and Wyatt, Alexander W.
- Published
- 2019
- Full Text
- View/download PDF
49. Long-Term Outcomes in Patients Using Protocol-Directed Active Surveillance for Prostate Cancer.
- Author
-
Newcomb, Lisa F., Schenk, Jeannette M., Zheng, Yingye, Liu, Menghan, Zhu, Kehao, Brooks, James D., Carroll, Peter R., Dash, Atreya, de la Calle, Claire M., Ellis, William J., Filson, Christopher P., Gleave, Martin E., Liss, Michael A., Martin, Frances, McKenney, Jesse K., Morgan, Todd M., Tretiakova, Maria S., Wagner, Andrew A., Nelson, Peter S., and Lin, Daniel W.
- Subjects
PROSTATE cancer ,WATCHFUL waiting ,PROSTATE cancer patients ,TREATMENT effectiveness ,PROSTATE-specific antigen ,CANCER patients - Abstract
Key Points: Question: What are the long-term outcomes for patients with prostate cancer whose cases are managed with protocol-directed active surveillance? Findings: In this multicenter cohort study that included 2155 individuals with a median follow-up time of 7.2 years, the 10-year incidence of upgrading at biopsy and definitive treatment were 43% and 49%, respectively. The 10-year incidence of metastasis or prostate cancer mortality were 1.4% and 0.1%, respectively. There was no significant difference in adverse outcomes in men treated within the first 2 years of surveillance vs later on. Meaning: Protocol-directed active surveillance is a safe management strategy for avoiding overtreatment and preventing undertreatment. Importance: Outcomes from protocol-directed active surveillance for favorable-risk prostate cancers are needed to support decision-making. Objective: To characterize the long-term oncological outcomes of patients receiving active surveillance in a multicenter, protocol-directed cohort. Design, Setting, and Participants: The Canary Prostate Active Surveillance Study (PASS) is a prospective cohort study initiated in 2008. A cohort of 2155 men with favorable-risk prostate cancer and no prior treatment were enrolled at 10 North American centers through August 2022. Exposure: Active surveillance for prostate cancer. Main Outcomes and Measures: Cumulative incidence of biopsy grade reclassification, treatment, metastasis, prostate cancer mortality, overall mortality, and recurrence after treatment in patients treated after the first or subsequent surveillance biopsies. Results: Among 2155 patients with localized prostate cancer, the median follow-up was 7.2 years, median age was 63 years, 83% were White, 7% were Black, 90% were diagnosed with grade group 1 cancer, and median prostate-specific antigen (PSA) was 5.2 ng/mL. Ten years after diagnosis, the incidence of biopsy grade reclassification and treatment were 43% (95% CI, 40%-45%) and 49% (95% CI, 47%-52%), respectively. There were 425 and 396 patients treated after confirmatory or subsequent surveillance biopsies (median of 1.5 and 4.6 years after diagnosis, respectively) and the 5-year rates of recurrence were 11% (95% CI, 7%-15%) and 8% (95% CI, 5%-11%), respectively. Progression to metastatic cancer occurred in 21 participants and there were 3 prostate cancer–related deaths. The estimated rates of metastasis or prostate cancer–specific mortality at 10 years after diagnosis were 1.4% (95% CI, 0.7%-2%) and 0.1% (95% CI, 0%-0.4%), respectively; overall mortality in the same time period was 5.1% (95% CI, 3.8%-6.4%). Conclusions and Relevance: In this study, 10 years after diagnosis, 49% of men remained free of progression or treatment, less than 2% developed metastatic disease, and less than 1% died of their disease. Later progression and treatment during surveillance were not associated with worse outcomes. These results demonstrate active surveillance as an effective management strategy for patients diagnosed with favorable-risk prostate cancer. This prospective, multicenter cohort study evaluates the long-term outcomes of men diagnosed with favorable-risk prostate cancer managed with protocol-directed active surveillance, including regular biopsies and prostate-specific antigen screening, from 2008 to 2022. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
50. Proceedings From the 5th B2B Uro-Oncology: GU Cancers Triad Meeting: Prostate Cancer
- Author
-
Tilki, Derya, primary, Canda, A. Erdem, additional, Esen, Taril, additional, Greene, Kirsten L., additional, Beltran, Himisha, additional, Bavbek, Sevil, additional, Ürün, Yüksel, additional, Gleave, Martin E., additional, Selek, Uğur, additional, Zhang, Tian, additional, Tanguay, Simon, additional, and Black, Peter C., additional
- Published
- 2023
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.